Sub-millimeter quantification of alveolar bone loss using automated 40 MHz high-frequency ultrasound: A proof-of-concept ex vivo validation study Authors: Tamer Abdelrehim, Baiyan Qi, Bryant Tran, Mirali Pandya, Jesse V. Jokerst, Casey Chen, Andrej Kielbassa, Andrej Kielbassa, Andrej Kielbassa, Andrej Kielbassa Published: 2026 ABSTRACT This proof-of-concept study evaluated the performance of high-frequency ultrasound (HFUS, 40 MHz) for monitoring changes in alveolar bone loss and determining its detection capability and measurement precision. The study aimed to quantify system error, minimum detectable change, and agreement with a photographic ground truth measurement. An ex vivo model was used in which controlled bone loss increments were created and measured using both manual and automated HFUS methods. Measurements were compared to calibrated photographic measurements as the reference standard. System error was calculated using repeated baseline measurements, and detection capability was assessed using sensitivity analysis across incremental bone loss values. Agreement between methods was evaluated using Bland–Altman analysis and intraclass correlation coefficients (ICC). The system error ranged from 77 µm for automated image-registration measurements to 113 µm for manual measurements. The minimum detectable bone loss increment was experimentally determined to be approximately 138 µm. Detection sensitivity ranged from 79% to 100%, depending on the measurement method and increment size. Automated ultrasound measurements showed strong agreement for longitudinal change tracking, with a best-case bias of −18 µm, corresponds to less than 10% error relative to a typical 200 µm bone change increment and excellent reliability (ICC = 0.89–0.99). No significant systematic bias was observed compared with photographic measurements (P > 0.05), indicating good agreement between methods. High-frequency ultrasound demonstrated the ability to detect small longitudinal changes in alveolar bone loss and to track bone loss progression over time with high measurement precision. The main contribution of this study is demonstrating that HFUS can be used as a radiation-free method for monitoring longitudinal changes in alveolar bone loss rather than relying solely on absolute measurement accuracy. Introduction Periodontitis is one of the two leading diseases in dentistry, along with dental caries [1], and is associated with tooth loss, reduced quality of life, and systemic conditions such as diabetes [2]. In patients suffering from periodontitis, bacteria-induced inflammatory responses destroy soft and hard tissues supporting the teeth (i.e., the periodontium) [3]. Conventional periodontal assessment combines clinical probing to evaluate soft tissue attachment loss with radiography to assess bone levels. While simple and universally accepted, probing cannot directly evaluate the underlying bone and is imprecise. Radiography, particularly plain films, remains the standard for bone assessment but possesses fundamental limitations that hinder early and accurate diagnosis. These include its two-dimensional projection of a three-dimensional anatomy, which obscures critical details through anatomical superimposition [4], and a well-documented insensitivity that requires substantial bone mineral loss before defects become visible [5]. While three-dimensional imaging such as CBCT can overcome some geometric limitations, its use of ionizing radiation and higher cost render it unsuitable for routine monitoring [6]. Furthermore, the subjective interpretation of radiographs can lead to underestimation or overestimation of bone levels, resulting in delayed diagnoses or inappropriate treatment decisions [7]. Significant progress has been made in automated three-dimensional diagnostic workflows, particularly with artificial intelligence systems applied to cone-beam CT (CBCT) and dental radiographic imaging. Recent studies have demonstrated AI-based detection, segmentation, and analysis of dental structures and alveolar bone from CBCT and radiographic images with high accuracy and reliability [8–12]. These systems can delineate complex anatomical structures and automate diagnostic workflows, establishing a new standard for volumetric assessment and digital dentistry. However, these AI-based systems are primarily designed for anatomical segmentation, structural detection, and treatment planning rather than for detecting small longitudinal bone changes with defined measurement precision and detection thresholds. As a result, a fundamental diagnostic gap remains in the quantitative monitoring of small bone-level changes over time. This gap between the dynamic progression of periodontitis and the static, insensitive nature of radiographic assessment highlights the need for a high-precision, radiation-free method capable of detecting small longitudinal bone changes, which is the focus of the present study. A tool capable of precisely measuring subtle bone-level changes with a defined minimum detectable threshold and low system error is still lacking, which may delay detection of early bone loss and progression of periodontal disease. High-frequency ultrasound (HFUS) is a promising, radiation-free imaging modality capable of imaging both hard and soft tissues and identifying key anatomical landmarks relevant to periodontal assessment [13,14]. The use of a 40 MHz transducer provides high axial resolution (~40 µm) [15], suggesting the potential to detect small bone-level changes beyond the detection capability of conventional radiography. Previous ultrasound studies for periodontal assessment have demonstrated the feasibility of ultrasonography for imaging periodontal and peri-implant structures [16 23]. Early studies using lower-frequency ultrasound systems (e.g., around 20 MHz) were able to visualize periodontal tissues but were limited by insufficient spatial resolution for detecting small bone-level changes [17]. More recent intraoral ultrasound studies have evaluated periodontal structures, crestal bone dimensions, and peri-implant tissues and have demonstrated good repeatability and clinical feasibility [18–23]. Photoacoustic imaging has also been explored for periodontal assessment [24]. However, many of these studies focused primarily on qualitative visualization, anatomical imaging, or single time-point measurements rather than quantitative validation of measurement precision, system error, and minimum detectable bone loss. In addition, earlier ultrasound systems often operated at lower frequencies with lower spatial resolution compared to modern high-frequency ultrasound systems [15,16,25]. Therefore, the present study differs from previous work by using a 40 MHz high-frequency ultrasound system and by focusing on quantitative validation of measurement performance, including system error, agreement analysis, and detection capability for small incremental bone loss. Periodontitis is a dynamic disease characterized by progressive tissue destruction over time, whereas most current diagnostic tools, particularly radiography, provide static assessments and are relatively insensitive to small longitudinal changes. The diagnostic window for early intervention is frequently missed because conventional radiographs require substantial mineral loss before defects become visible. Therefore, a measurement method capable of detecting small longitudinal changes with high precision may be more clinically valuable for monitoring disease progression than methods focused solely on absolute bone level measurements. Therefore, the purpose of this study was to quantify the measurement performance of high-frequency ultrasound for detecting and monitoring alveolar bone loss using a controlled ex vivo model. Specifically, we aimed to (i) quantify the system error of ultrasound measurements and compare them to photographic reference measurements, and (ii) determine the minimum amount of bone loss that can be reliably detected. The null hypothesis of this study was that high-frequency ultrasound measurements would not differ significantly from photographic reference measurements for quantifying alveolar bone loss and would not be capable of detecting small incremental bone loss changes. Therefore, this study does not aim to replace radiography for absolute bone level measurement, but rather to determine whether high-frequency ultrasound can detect small longitudinal changes in alveolar bone loss with high precision and a defined detection threshold. Materials and methods Ex vivo model and defect creation A mandible from a 6-month-old male Yorkshire swine was procured from a USDA-approved abattoir. Three teeth (M2, M3, and PM4) were analyzed across multiple standardized bone-loss stages (baseline + incremental bone removal), each measured by three blinded examiners using multiple independent frames per stage in addition to the automatic measurement methods. This design generated a robust dataset suitable for quantitative analysis and inter-observer validation. The specimen was transported on ice and stored at −20 °C immediately upon receipt. Twenty-four hours before experimentation, it was thawed at 4 °C and sectioned along the sagittal plane to isolate segments containing the selected teeth. The teeth were chosen based on consistent anatomical morphology, intact buccal bone plates, and accessibility for standardized defect creation. An intrasulcular incision was made from the distobuccal area of the third mandibular molar (M3) to the mesiobuccal area of the fourth mandibular premolar (PM4) using a #15 surgical blade (Henry Schein Inc., Melville, NY, USA). A full-thickness mucoperiosteal flap was elevated with a periosteal elevator (#9 Molt double-ended periosteal elevator; Henry Schein Inc., Melville, NY, USA) to expose the underlying alveolar bone. Small holes were drilled on the buccal surface at the central region of each tooth (M3, M2, and PM4), approximately 3–4 mm above the initial alveolar bone level and within the lateral FOV for ultrasound frame. Stainless steel ball markers (1 mm diameter) were fixed in the drilled holes using cyanoacrylate adhesive (Gorilla Super Glue; Gorilla Glue Company, Cincinnati, OH, USA) to serve as stable fiducial reference markers for calibration, motion tracking, and bone level measurements [14]. Two steel balls were positioned above and below the initial alveolar bone level to provide a two-point reference for pixel-to-micron calibration. Under ultrasound scan, these reference steel balls are a clear ultrasound ring marker that ensure comparison of the same frame between different bone loss stages at different times. The mandibles were then secured on a C-clamp holder with articulating platforms (Thorlabs, Inc., Newton, NJ, USA) [26]. The distance between steel balls on each tooth was measured using a digital caliper with 0.01-mm resolution (Neiko Tools USA, CA, USA). The markers were placed in the central buccal region to minimize mesial and distal anatomical variations and to ensure consistent vertical reference measurements. This method was used only for the ex vivo experimental model and is not intended for clinical application. For clinical ultrasound measurements, the cementoenamel junction (CEJ) was used as the anatomical reference point. The use of fixed reference markers in this study is conceptually similar to our previous studies [14] in which use of fixed structures, such as the steel balls, were used as reference points for measuring the position of CEJ using imaging HFUS. The buccal bone was removed incrementally using a double-ended bone chisel (13K/13KL; Henry Schein Inc., Melville, NY, USA) and a #2 Ochsenbein single chisel (Henry Schein; Henry Schein Inc., Melville, NY, USA). Six stages of bone removal were prepared for teeth M3 and PM4, and four stages for tooth M2. The amount of bone removed at each stage was targeted to ~200 µm increments by an experienced operator. The precise, final amount of bone loss for each stage was subsequently determined by post hoc photographic ground truth measurement, and these values were used for all subsequent analyses. While the manual creation process introduced some variability in defect morphology, the subsequent post hoc quantification provided the robust ground truth. The removal was then quantified by comparing the photographic ground truth measurements between stages. Study design and sample considerations This study was designed as a methodological proof-of-concept and system validation study rather than a clinical hypothesis-testing study; therefore, a formal a priori sample size calculation was not performed. A post hoc power analysis was conducted (see Supporting Information S1 Text) to assess the statistical sensitivity of the experimental design [27–29]. The experimental design focused on repeated measurements across controlled bone loss stages to quantify system error, agreement, and detection capability, which were the primary outcomes of this validation study. The use of a single mandible specimen represents convenience sampling, and no randomization was performed. However, the large number of repeated measurements across stages and independent observers allowed robust estimation of measurement variability, system error, and agreement statistics, which were the main objectives of this methodological validation study. The post hoc power analysis, based on the observed detection threshold (138 µm), system error range (77–113 µm), and repeated-measurement design, indicated a large, standardized effect size (Cohen’s d ≈ 1.22–1.79) and an estimated statistical power exceeding 95%, supporting the adequacy of the study design for detecting clinically relevant bone loss changes. Specimen selection criteria A single porcine mandible specimen with intact teeth and surrounding alveolar bone was selected for the ex vivo model. Teeth with visible fractures, severe anatomical defects, or existing bone loss were excluded. The specimen was selected to provide stable anatomical landmarks and intact alveolar bone for controlled defect creation and measurement validation. Image acquisition Photographic ground truth setup. Throughout all bone removal stages, the jaw segment was consistently fixed at a predefined marked position using the same C-clamp holder with articulating platforms to ensure identical alignment and precise repositioning. High-resolution photographs were acquired using a 12-megapixel CMOS camera (EOS Rebel T3; Canon Inc., Tokyo, Japan) under flash and standard room lighting conditions (ISO-800, f/5.6, and exposure time: 1/60 sec) equipped with a 100-mm macro lens (Canon Inc., Tokyo, Japan). The camera was mounted on a stand to maintain a consistent orthogonal view and a fixed focal distance of 120 ± 1 mm, minimizing parallax error. The setup included controlled lighting, and images were captured using the camera’s built-in software connected to a PC to eliminate hand movement during capture. At each bone loss stage, the separated gingiva was held with tweezers to expose the profile of enamel and alveolar bone with fixed steel ball fiducial markers, and four frames were recorded. The known, pre-measured distance between the fixed fiducial markers (steel balls) was used to calibrate a pixel-to-micron ratio for each image, providing a consistent scale. This calibration yielded an average photographic pixel size of 18.0 ± 0.5 µm. This photographic setup provided the reference (“gold standard”) measurement for bone level changes. Ultrasound imaging setup Ultrasound imaging was performed using a high-frequency ultrasound imaging system (Vevo F2; FUJIFILM VisualSonics, Toronto, ON, Canada) [30] equipped with a linear-array transducer (UHF57x; FUJIFILM VisualSonics, Toronto, ON, Canada) having a center frequency of 40 MHz. The transducer’s specified axial and lateral resolutions were 40 µm and 90 µm, respectively. Acoustic coupling was achieved using a hydrogel pad [31] fixed and covered by a transparent sheet (Tegaderm™ Pad Film Dressing; 3M Company, St. Paul, MN, USA), with a small amount of Ultrasound transmission gel (Aquasonic® Clear Ultrasound Gel; Parker Laboratories, Inc., Fairfield, NJ, USA) applied between the sheet and the surface of the target tooth to ensure proper acoustic coupling. The transducer was hand-held to manually adjust the B-scan orientation, simulating a clinical scenario; the operator’s hand was braced against the fixed C-clamp holder to enhance stability. While this approach introduces potential operator-dependent variability in transducer positioning and contact pressure, it represents a necessary step towards clinical realism. The scanning protocol focused on capturing a consistent profile that included the two reference steel balls, the enamel surface, the gingiva, and the underlying alveolar bone crest. This approach ensured that the same anatomical cross-section could be compared across different bone loss stages. A voice-command acquisition function integrated into the ultrasound system (Vevo Scan; FUJIFILM VisualSonics, Toronto, ON, Canada) was used to trigger each acquisition to minimize examiner movement. For each scan position, one hundred frames with dimensions of 14 by 14 mm were collected at a frame rate of 51 frames per second. A single, representative frame was then selected for analysis based on objective criteria, including a adequate frame clarity within a defined region of interest (ROI) over the bone crest, and the simultaneous, clear visualization of the CEJ, alveolar bone crest, and both fiducial markers, with a complete absence of motion artifacts. This selected frame was saved in.tiff format for subsequent analysis. The system was configured in abdominal mode with the following parameters, which were standardized across all acquisitions to ensure comparability: a dynamic range of 58 dB, and an image depth and width of 14 mm to consistently encompass the entire region of interest, including the fiducial markers, enamel surface, and alveolar bone crest. A focal depth of 7 mm was selected to optimize lateral resolution at the estimated average depth of the alveolar bone crest. The gain was set to 0 dB, as this default setting provided optimal contrast for hard tissue interfaces without signal saturation during preliminary testing. Measurement techniques To evaluate alveolar bone loss, we employed five distinct measurement strategies, which can be grouped into two primary categories: Manual measurements by blinded observers and Automated algorithms. These were applied to both the photographic ground truth and the ultrasound images, as summarized in Table 1. 10.1371/journal.pone.0349815.t001Table 1Summary of measurement methods.CategoryMethod nameAcronymDescriptionModality Manual Manual Blinded Observers – CameraManual-BO-CAManual tracing by experts using photographic images.CameraManual Blinded Observers – UltrasoundManual-BO-USManual tracing by experts using ultrasound images.Ultrasound Automated Automatic Camera AnalysisAuto-CAAutomated analysis of photographic images.CameraDirect Tracing Superposition – UltrasoundDTS-USAutomated, frame-registration-based measurement of bone crest displacement.UltrasoundAuto-SVD-Compounded UltrasoundAuto-SVD-USAutomated, SVD-enhanced measurement of CEJ-to-ABC distance.Ultrasound Summary of measurement methods. Manual blinded observers (Manual-BO-US) A manual measurement protocol was executed by three blinded examiners (Ex1, Ex2, Ex3) to ensure objective and reliable data collection for both the photographic ground truth and ultrasound images. The alveolar bone loss for a given stage was calculated as the difference in the position of the ABC relative to a fixed marker between consecutive stages. Examiners measured the distance from a defined point on the superior steel ball to the bone crest. The specific reference point was chosen based on the most reliable and reproducible landmark identifiable in each imaging modality (the center of the steel ball for photography and the top tip for ultrasound): To obtain measurement by photography, the center of the steel ball was used, determined by manual annotation in the orthogonal photographic view, as this point is unambiguous and invariant. In ultrasound Analysis, the top tip (the most superficial hyperechoic point) of the steel ball’s cross-sectional profile in the B-scan was used. This point was selected because it represents the first and most consistent acoustic reflection from the steel ball, providing a stable and repeatable landmark in the ultrasound image, whereas the geometric center cannot be reliably determined due to acoustic artifacts like reverberation (false echoes appearing deeper than the true reflector) and shadowing (reduced signal intensity behind highly reflective structures). This modality-specific adaptation is a necessary consideration in multimodal imaging comparisons. This difference in reference points introduces a fixed, constant offset between the two modalities, equal to the radius of the steel ball (500 µm). Since all analyses are based on the change in distance between consecutive stages, this constant offset is canceled out and does not contribute to the measured bone loss values or the bias reported in the Bland-Altman analysis. To prevent bias, the examiners were blinded to the bone loss stage and each other’s results. This was achieved by providing each examiner with a fully randomized and anonymized set of images. Images from all teeth (M2, M3, PM4) and all stages were pooled and assigned random codes, ensuring that consecutive stages of the same tooth were not analyzed sequentially. The examiners had no knowledge of the amount of bone removed or previous measurement data. For photographic analysis, measurements were performed using image analysis software (ImageJ; National Institutes of Health, Bethesda, MD, USA). Examiners manually annotated the defined points (ball center and bone crest) to calculate the distance between the ball and bone crest. Each examiner analyzed four distinct frames per stage, repeating the measurement process three times per frame. For ultrasound image analysis, the same protocol was followed using ultrasound analysis software (Vevo-lab; FUJIFILM VisualSonics, Toronto, ON, Canada) [32]. Examiners were trained to use the software’s built-in digital caliper tool for all linear distance measurements. Examiners were instructed to zoom in on the region of interest for precise point placement, targeting the most apical point of the hyperechoic ABC and the top tip of the superior steel ball’s profile for each measurement. Examiners were given explicit guidelines for identifying the reference steel ball tip and the bone crest signal, which appears as a distinct, strong, and spatially coherent reflection. They were instructed to disregard isolated speckle artifacts, which present as transient, less organized, and typically weaker point-like reflections. This replication resulted in 36 measurements per stage per modality (4 frames × 3 repetitions × 3 examiners). The values from all replicates were averaged per examiner for subsequent analysis. Representative examples at tooth PM4 and M3 of the ABC visualization and the manual measurement protocol for both photography and ultrasound are provided in Fig 1. Visualization of alveolar bone crest using photography and ultrasound. (a) A normal view of the Canon camera captures a fixed pig jaw. The alveolar bone was exposed by reflecting the overlying gingiva. Two steel balls were fixed on each tooth site as fiducial markers. (b) A cropped image section frame of tooth PM4 under photographic camera showing the yellow double arrow between the 1st steel ball and the bone crest aligned with the dashed red line which is the tested comparable plane between the two fixed balls, (c) The corresponding ultrasound frame at B-mode section frame scanned by Vevo F2 with a 40 MHz ultrasound transducer, the distance of yellow double arrow between the 1st steel ball and the bone crest ABC was measured. The distance of the red double arrow in (c) is corresponding with the distance of the yellow double arrow in (b). The fixed steel ball can be distinguished by a ring down echo as shown clearly at the ultrasound scan. (d) is a schematic diagram of a cross-section profile with no bone loss. Panels (e) and (f) represent the alveolar bone crest of tooth M3 following six stages of alveolar bone mechanical removal. (e) Photographic frames captured by a Canon camera. (f) Ultrasound scanning using a 40 MHz ultrasound array transducer, where the green dashed line is the alveolar bone crest level before bone removal. ABC (No loss): alveolar bone crest level with no bone loss, T: tooth enamel, B: alveolar bone, gingiva margin GM, and G: gingiva. The length of the yellow lines at panels (e) and (f) is the change in the amount of bone level detected at different alveolar bone loss stages. The fixed steel balls can be distinguished in panel (f) by a ring down echo as shown clearly at the ultrasound scan. Automated measurement algorithms Two complementary automated algorithms were developed using technical computing software (MATLAB R2023a; MathWorks, Natick, MA, USA) [33] to provide objective and precise quantification of alveolar bone loss (S1 Code). Both methods utilize the CEJ as a stable anatomical reference point, offering a more clinically relevant framework than external markers such as the steel balls used in this study for the blinded observers’ method. Rather than relying on a deep learning-based approach, which requires many annotated image datasets, we developed a distinct methodology by optimizing traditional image processing techniques for 40 MHz HFUS data. This approach offers transparency and ease of use, making it suitable for our proof-of-concept study. This included the application of Singular Value Decomposition (SVD) filtering for noise reduction [34,35] and intensity-based registration for alignment, which are particularly suited to address the challenges of speckle noise and subtle hard-tissue interfaces characteristic of this modality. All algorithms were implemented using technical computing software and its image processing toolbox (MATLAB R2023a with Image Processing Toolbox; MathWorks, Natick, MA, USA) [33]. Fig 2 e shows a flowchart of the two algorithms for measuring the alveolar bone by HFUS, the methods are described in detail in the following sections. Ultrasound-based assessment of alveolar bone loss using DTS-US method (at molar M2). Panels (a) and (b) represent the raw ultrasound frames at the 2nd and 3rd loss stages, the fixed steel ball can be distinguished by a ring down echo as shown clearly at the ultrasound scan. Panels (c) and (d) represent the frame superposition method. Consecutive frames are overlaid to measure the displacement of the alveolar bone crest (ABC) between both frames. In (c), red/green overlays demonstrate frame registration and displacement tracking across stages (2nd and 3rd loss stages). The tooth enamel surface and cemento-enamel junction “CEJ” coincide, while the shift between ABCs directly quantifies bone loss measurement. In (d), the raw intensity difference map between consecutive frames confirms optimal overlay adjustment and highlights the ABC displacement. The gingiva surface shows high intensity due to different separated gingiva positions at different stages and the pressure force difference of the handheld transducer on the gingiva surface. Panel (e) shows a flowchart of the two quantification methods for bone loss measurement: DTS-US and Auto-SVD-US. Anatomical landmarks: gingiva “G”, gingiva margin tooth “GM”, enamel “T”, alveolar bone “B”, cemento-enamel junction “CEJ”, in red at raw images (a) and (b), and in white at superposition images (c) and (d), alveolar bone crest “ABC” in yellow. Method 1: Direct tracing superposition (DTS-US) This method quantified bone loss by directly measuring the displacement of the ABC between two consecutively acquired stages through image registration and subtraction. Fig 2 a-d shows an example of applying DTS-US on a molar M2 between 2nd and 3rd bone loss stages for measuring the direct shift of ABCs, which is considered as a bone loss between 2nd and 3rd stages. The method as shown in (S1 Code) has the following processing steps for (DTS-US): One-Time CEJ Annotation On the baseline image (No bone loss stage), the CEJ point was manually annotated by an expert observer (TA) to serve as a fixed anatomical reference. This CEJ and enamel surface are used as landmarks for the superposition of approximately the same position frames, ensuring a reliable starting point. Interactive Alignment and Manual Measurement A semi-automated workflow began with initial automatic alignment using edge-based registration to optimize enamel surface matching across translation and rotation parameters [36–38]. Following this computational alignment, expert user (TA) interactively refined the registration through real-time sliders for precise translational (±500 pixels) and rotational (±90°) adjustments, supported by live visual feedback from composite overlays and difference maps. Superposition and direct ABC displacement vector measurement After precise registration, the frames were superimposed. The bone loss was quantified by automatically computing the displacement vector of the ABC. This was achieved by first generating a difference map from the superimposed images. The ABC in the previous stage (N-1) was used as a reference point, and its new position in the current stage (N) was identified as the peak of the intensity difference profile along a direction normal to the enamel surface. The magnitude of this vector represented the bone change between the two stages. Method 2: Auto-SVD-compounded ultrasound measurement (Auto-SVD-US) The Auto-SVD-US method was developed to measure alveolar bone loss by leveraging multi-frame compounding and noise suppression. This method uses Singular Value Decomposition (SVD) [34,35] to create a single, enhanced image from four frames acquired at different time points for every bone loss stage. Bone loss was calculated as the change in the absolute distance from the CEJ to ABC between consecutive stages. Fig 3 shows an example of applying Auto-SVD-US on the premolar PM4, from no bone loss to 6th bone loss stage and shows the comparably enhanced frame after the SVD combined filter at each stage over the raw collected frames. Ultrasound-based assessment of alveolar bone loss using image quantification method Auto-SVD-US at premolar PM4. Image rows at (a-g) representative application of the automated method across staged bone loss defects: (no bone loss to 6th loss) respectively. Four sequential B-mode ultrasound frames were collected (Frame#1 to #4), with the last column showing the comparable enhanced combined frame after SVD filtering. CEJ coordinates were obtained by overlaying each stage with the baseline (no-loss) frame, and ABC was automatically detected. The horizontal CEJ-ABC distance was then measured at each stage to quantify bone loss. Anatomical landmarks: gingiva (G), tooth enamel (T), alveolar bone (B), Cemento-enamel junction (CEJ, red), alveolar bone crest (ABC, yellow). Anatomical landmarks: gingiva (G), tooth enamel (T), alveolar bone (B), Cemento-enamel junction (CEJ, red), alveolar bone crest (ABC, yellow). The method as shown in (S1 Code) has the following processing steps for (Auto-SVD-US): Multi-frame acquisition and preprocessing For each examination stage, four sequential ultrasound frames were acquired from an approximately identical region of interest (ROI) centered on the target tooth, acknowledging the practical constraint of perfect repositioning. All frames underwent manual ROI selection to ensure consistent anatomical coverage. The system standardized frame dimensions through an automated center-cropping and zero-padding algorithm to maintain spatial consistency. Each frame was converted to double-precision format, normalized, and any non-finite values were handled through zero-replacement to ensure mathematical integrity for subsequent processing. Rigid registration and frame alignment To establish a common spatial framework, an intensity-based rigid registration was performed. The first frame served as the reference. Using a mean squares metric and a regular step gradient descent optimizer (300 maximum iterations), each subsequent frame was transformed to align with the reference. The selection of 300 iterations was empirically determined to balance computational efficiency and processing time with registration accuracy, ensuring robust convergence across diverse image qualities. This step corrected for global translational and rotational shifts, ensuring that the alveolar bone structures were spatially congruent across all four frames before compounding. SVD filter for noise suppression and image compounding To suppress uncorrelated noise and enhance the coherent topographic signal, the stack of four registered frames was processed using Singular Value Decomposition (SVD) [34,35]. The procedure was as follows: First, the image stack was reshaped into a two-dimensional matrix A of dimensions (pixels) × (frames). Specifically, with an image resolution of h (height) × w (width) and four frames, the matrix A was constructed by vectorizing each frame, resulting in dimensions of (h × w) × 4. Each column of A represented a single frame vectorized into a one-dimensional array. This matrix was then decomposed using an economy-size SVD, factorizing it into three constituent matrices: Where: U is an (h × w) × 4 orthogonal matrix whose columns represent spatial components, or eigen images, of the input data. Σ is a 4 × 4 diagonal matrix containing the singular values (σ1 to σ4) in descending order. These values quantify the energy or significance of each corresponding spatial component in U. VT is a 4 × 4 orthogonal matrix whose rows represent the temporal components, describing how the spatial modes are weighted across the different frames. A low-rank approximation was applied to filter the data. This was achieved by retaining only the most significant singular values, which correspond to the coherent bone topography, while discarding lower-value components associated with random noise and residual artifacts. For this analysis, the singular value matrix was truncated to retain only the first two components, preserving the primary spatial signal of the anatomy while effectively suppressing noise-dominated higher-order components. The filtered matrix A′ was reconstructed via A′=U*Σ′*VT. where Σ′ represents the truncated singular value matrix. Finally, this matrix was reshaped back into its original spatial dimensions (h × w). The final, SVD-compounded image for the stage was extracted as the first spatial component (the first column of U), which provides the purest representation of the bone topography with effectively suppressed noise. In ultrasound imaging, speckle noise is largely uncorrelated between frames, whereas structural anatomical features such as bone and enamel interfaces remain spatially coherent; therefore, SVD allows separation of coherent anatomical structure from incoherent speckle clutter through low-rank approximation. Automated landmark identification and distance measurement The SVD-compounded image for each stage was used for quantitative analysis. Key anatomical landmarks, the CEJ, ABC, and a steel ball reference marker were automatically detected using intensity gradient analysis and surface fitting algorithms. The tooth surface was traced using adaptive thresholding. The absolute distance from the CEJ to the ABC was automatically computed in pixel coordinates and converted to physical dimensions (micrometers) using a calibrated pixel size of 18.24 µm. Longitudinal bone loss quantification The entire previous process (steps 1−4) as repeated independently for each consecutive bone removal stage (e.g., Stage N and Stage N-1), resulting in two stable, high-quality measurements. The bone loss between two consecutive stages was then computed as the difference in the CEJ-to-ABC distances: A positive Δ value indicates bone loss, as the CEJ-to-ABC distance increases, while a negative value would suggest a measurement anomaly. This approach condenses the analysis from 4 potential cross-comparisons (4 frames vs. 4 frames) to a single, highly reliable comparison between two SVD-enhanced consensus images, dramatically improving efficiency and precision. Interactive visualization and data export The system provided multi-modal visualization with overlays of tissue boundaries, landmarks, and measurement lines. All data, including processed images, measurement results, and analysis parameters, were exported to standardized formats, including spreadsheet files (Microsoft Excel; Microsoft Corporation, Redmond, WA, USA), MATLAB files (MathWorks, Natick, MA, USA), and high-resolution image files for documentation and further analysis. In the Auto-SVD-US algorithm, several parameters were fixed across all datasets, including the SVD threshold selection range, filtering window size, and CEJ detection parameters. User-defined inputs were limited to region-of-interest selection and image cropping. Parameter values were selected based on preliminary testing to maximize signal stability and boundary detection accuracy. The MATLAB implementation and processing workflow will be made available upon request to support reproducibility (S1 Code at supporting Information). In summary, Method 1 (DTS-US) provided a direct measurement of bone crest displacement through consecutive image subtraction, ideal for visualizing incremental changes. Method 2 (Auto-SVD-US) offered a highly efficient and automated workflow by leveraging multi-frame averaging and absolute distance measurements. The congruence of results from these two independents, CEJ-based methods provided robust validation for the bone loss measurements using high-frequency ultrasound. Quantitative image quality assessment and landmark identification To objectively evaluate the enhancement provided by the SVD-compounding algorithm, the Signal-to-Noise Ratio (SNR) was calculated for each individual frame and the final compounded result. The SNR was defined as 20·log10 (Mean_Signal/ Std_Noise). The signal region was defined as the central area of the image, spanning from 25% to 75% of its height and width to encompass the alveolar bone. To ensure robustness, pixels with intensities below 1% of the frame’s maximum value were excluded from the calculations. For the automated measurement of bone loss, the Cemento-Enamel Junction (CEJ) was established as a fixed reference point on the baseline (no bone loss) SVD-compounded image. This coordinate was then propagated to all subsequent bone loss stages via intensity-based rigid registration, which aligned the enamel surfaces across time points. This strategy ensured a stable and consistent anatomical reference, making the measurement robust to the intermittent invisibility of the CEJ in individual B-mode frames due to acoustic shadowing. Data and statistical analysis Definition of system error. The inherent precision of each measurement system, defined as the system error, was determined from repeated measurements under unchanged conditions at the baseline (“no loss”) stage. For each method, the apparent “bone loss” was calculated between replicate measurements where no anatomical changes occurred. The system error was calculated as the mean of these apparent changes plus two standard deviations (Mean + 2SD), establishing a one-sided upper threshold for measurement noise corresponding to the 97.5th percentile under a normal distribution [39]. Baseline measurement error distributions were visually inspected using histograms and were found to be approximately normally distributed; therefore, the Mean + 2SD threshold criterion was considered appropriate. Since bone loss is a unidirectional process, this one-sided threshold was used as the statistical criterion, and any measured change in subsequent stages exceeding this threshold was considered a true-positive detection of bone loss. For clarity, three related statistical concepts were defined in this study. System error represents the inherent variability of a measurement method under unchanged conditions and defines the noise floor of the measurement system. The minimum detectable change (MDC) represents the smallest change that can be distinguished from measurement variability with statistical confidence and is a theoretical statistical threshold derived from system variability. In contrast, the empirical detection threshold was determined experimentally as the smallest actual bone loss increment that was consistently detected above the system error threshold across incremental bone loss stages. Any measured change in subsequent stages exceeding this threshold was considered a true-positive detection of bone loss. The number of measurements (N) used to calculate the system error differed by method, reflecting their distinct operational workflows: Manual-BO-US: N = 180. This represents the total number of manual annotations performed by the three blinded examiners on the baseline frames. The apparent change was calculated as the difference between each individual measurement and the shortest measurement at baseline. DTS-US: N = 20. This method quantifies the change between two frames. The system error was calculated from all possible pairwise comparisons between the four ultrasound scans acquired at each of the five independent baseline events. Auto-SVD-US: N = 20. This method generates a single denoised composite image per independent baseline acquisition event. The system error was calculated as the Mean + 2SD of the distribution of 20 absolute CEJ-to-ABC distance values measured from these baseline composites. Baseline measurement error distributions were visually inspected using histograms and were found to be approximately normally distributed; therefore, the Mean + 2SD threshold criterion was considered appropriate. Confidence intervals for sensitivity and specificity were calculated where applicable; however, due to the limited number of independent bone loss events, these intervals may be wide and should be interpreted cautiously. Statistical analysis Agreement between ultrasound measurements and photographic measurements was evaluated using Bland–Altman analysis, including mean bias and limits of agreement. Reliability between measurement methods and observers was assessed using intraclass correlation coefficients (ICC). Linear regression analysis was performed to evaluate the relationship between ultrasound and photographic measurements. Detection capability was evaluated using sensitivity analysis at each bone loss increment stage. A measurement was considered a true-positive detection when the measured bone loss exceeded the system error threshold. Detection sensitivity was calculated as the proportion of true-positive detections at each bone loss increment stage. Statistical significance was defined as P < 0.05. All statistical analyses were performed using MATLAB (MathWorks, Natick, MA, USA). Agreement and reliability analysis Bland-Altman analysis was employed to assess the agreement between measurement methods through a series of pairwise comparisons. The limits of agreement (LOA) for each comparison were calculated as the mean difference (bias) ± 1.96 times the standard deviation of the differences. Reliability was assessed using intraclass correlation coefficients (ICC), calculated from a two-way random-effects analysis of variance (ANOVA). The analyses were performed separately for each tooth (M3, M2, PM4). To evaluate the consistency between different measurement techniques, the ICC(2,1) model for absolute agreement among single measures was applied to two sets of comparisons: first, among all methods [Auto-SVD-US, DTS-US, Manual-BO-US, Auto-CA, Manual-BO-CA], and second, among the ultrasound methods exclusively [Auto-SVD-US, DTS-US, Manual-BO-US]. To quantify inter-observer variability for the manual measurements, the ICC(2,1) model for absolute agreement among single measures was also used separately for the manual photographic data [Manual-BO-CA_Ex1, Manual-BO-CA _Ex2, Manual-BO-CA_Ex3] and the manual ultrasound data [Manual-BO-US_Ex1, Manual-BO-US_Ex2, Manual-BO-US_Ex3]. ICC values were interpreted as follows: < 0.50 poor, 0.50–0.75 moderate, 0.75–0.90 good, and >0.90 excellent reliability. Due to the limited number of independent experimental units inherent to this proof-of-concept design, formal normality testing was not systematically performed. Instead, baseline error distributions were visually inspected and found to be approximately normal. Accordingly, ANOVA- and ICC-based analyses were applied as measures of internal consistency and reliability within a repeated-measurement framework rather than for population-level inference. Detection of bone level changes and diagnostic accuracy The diagnostic capability of ultrasound to detect the presence of bone loss was assessed by calculating sensitivity and specificity. A measured change was classified as a true positive only if it exceeded the method-specific system error threshold. Changes within this noise range were considered false positives. Sensitivity was calculated as the proportion of actual bone loss stages (as defined by the ground truth) that were correctly identified. Specificity was calculated as the proportion of no-bone-loss stages (pairwise comparisons at baseline) that were correctly identified as such. The system error (Mean + 2SD of baseline noise) establishes the threshold for a single measurement to be considered a real change [40]. Results The ex vivo bone loss model was generated in sequential stages, comprising six stages of bone loss plus one control stage for teeth M3 and PM4 and four stages plus two control stages for tooth M2. No datasets were excluded from the analysis, and all acquired images and measurements were included in the statistical evaluation. The precision of detecting changes was verified using photographic ground truth images, yielding a mean incremental bone loss of 215 ± 35 µm (range: 180–250 µm) per stage. Statistical comparisons between measurement methods were performed using regression analysis, intraclass correlation coefficient (ICC) analysis, and Bland–Altman agreement analysis. A significance level of P < 0.05 was used. Validation of the ground truth and model Fig 4, panels (a, b, and c) show scatter plots comparing three distinct ultrasound measurement methods for representative teeth (M3, M2, PM4) across all bone loss stages: manual measurements by blinded observers (Manual-BO-US), registered frame comparison (DTS-US), and the automated SVD-based method (Auto-SVD-US). Panel (d) shows regression lines comparing all ultrasound methods and the automated photographic method (Auto-CA) against the ground truth (Manual-BO-CA). The data plots reveal that all methods track progressive bone loss with high consistency, showing minimal divergence, clear separation between consecutive stages, and similar response patterns. Comparisons between ultrasound measurement methods of alveolar bone loss and camera measurement methods. Panels (a-c) show scatter plots of different ultrasound methods used at teeth M3, M2, and PM4, respectively (DTS-US: direct tracing superposition; Manual-BO-US: manual measurement by blinded examiners; Auto-SVD-US: automatic method after SVD filter). Panel (d) shows regression fits for the ultrasound methods and the automated camera method (Auto-CA) plotted against the manual camera ground truth (Manual-BO-CA). Panels (e-g) show Bland-Altman analysis between the ultrasound measurement methods. compared with Manual-BO-CA. Panels (h-j) show Bland-Altman analysis for each manual ultrasound examiner (Ex1, Ex2, and Ex3 respectively) compared with Manual-BO-CA. UL: Upper LOA, LL: Lower LOA. Regression analysis demonstrated significant correlations between ultrasound measurements and the photographic ground truth. Manual-BO-US showed the strongest correlation (R² = 0.55, P = 0.0001), followed by Auto-CA (R² = 0.53, P = 0.0002), DTS-US (R² = 0.46, P = 0.0008), and Auto-SVD-US (R² = 0.41, P = 0.0016). These results confirm that the ultrasound methods were able to track incremental bone loss consistently across all stages. Performance of measurement methods: system error and reliability The precision and reliability of all five measurement methods were systematically evaluated. System error, representing the inherent measurement variability, was calculated from repeated baseline measurements, while intraclass correlation coefficients (ICC) assessed reliability across different comparisons. As shown in Table 2, DTS-US showed the lowest system error (77 µm) among the ultrasound measurement methods, while Manual-BO-US exhibited the highest variability (113 µm). 10.1371/journal.pone.0349815.t002Table 2System error thresholds for different measurement methods (Mean + 2SD of baseline measurement noise).Measurement methodSystem error (Mean + 2SD, µm) Manual-BO-CA 81 Auto-CA 94 Manual-BO-US 113 DTS-US 77 Auto-SVD-US 111 System error thresholds for different measurement methods (Mean + 2SD of baseline measurement noise). ICC values revealed excellent reliability across all comparisons (Table 3). Inter-observer reliability was outstanding for both manual measurements by blind observers using Manual-BO-CA (ICC = 0.92) and Manual-BO-US (ICC = 0.98). Inter-method reliability among all five methods of ultrasound and camera ranged from ICC = 0.89 to 0.99 across different teeth. Inter-method reliability among all three ultrasound methods ranged from ICC = 0.86 to 0.98 across different teeth. The high ICC values across all comparisons, combined with low system errors, confirm that all measurement methods provide reliable and consistent results, with automated methods performing comparably to manual ground truth measurements. 10.1371/journal.pone.0349815.t003Table 3Intraclass correlation coefficient (ICC) for reliability analysis.ComparisonICC Value95% Confidence intervalInterpretationInter-Observer (Manual-BO-CA)0.92[0.88, 0.95]ExcellentInter-Observer (Manual-BO-US)0.98[0.97, 0.98]Excellent Inter-Method (All 5 Methods) at tooth (M3) 0.89[0.82, 0.95]Good Inter-Method (All 5 Methods) at tooth (M2) 0.99[0.991, 0.997]Excellent Inter-Method (All 5 Methods) at tooth (PM4) 0.92[0.89, 0.96]Excellent Inter-Method (Ultrasound Methods) at tooth (M3) 0.86[0.75, 0.96]Good Inter-Method (Ultrasound Methods) at tooth (M2) 0.98[0.96, 0.99]Excellent Inter-Method (Ultrasound Methods) at tooth (PM4) 0.90[0.82, 0.97]Excellent Intraclass correlation coefficient (ICC) for reliability analysis. Agreement between ultrasound and photographic ground truth The agreement between ultrasound-based measurements and the photographic ground truth was comprehensively assessed using Bland-Altman analysis across all measurement scenarios and examiner pairs. Primary method comparisons Across all modalities, ultrasound-based methods showed agreement with camera-based measurements (S1 Table), as illustrated in Fig 4. Panels (e-g) show Bland-Altman plots for the three primary ultrasound methods (Manual-BO-US, DTS-US, Auto-SVD-US) compared to the manual camera ground truth, while panels (h-j) show the same comparison broken down by individual examiner for the Manual-BO-US method. The Auto-SVD-US vs Manual-BO-CA comparison demonstrated the smallest bias was –18 µm, indicating no systematic over- or under-estimation. The best-case bias of −18 µm corresponds to less than 10% error relative to a typical 200 µm bone change increment, indicating clinically acceptable agreement for longitudinal monitoring applications. However, the limits of agreement were −418 µm to 381 µm, representing a range of 799 µm. This wide range indicates that for any single measurement, the difference between this automated ultrasound method and the photographic standard could be substantial. The DTS-US vs Manual-BO-CA comparison showed a slightly larger bias of 86 µm, with limits of agreement between –336 µm to 508 µm, with a range of 844 µm. The Manual-BO-US vs Manual-BO-CA comparison showed a bias of 30 µm corresponds to 15% error relative to a typical 200 µm bone change increment and limits of agreement between –307 µm to 369 µm, with a range of 676 µm. Inter-observer and cross-modal variability S1 Table further provides crucial insights into variability through inter-observer and cross-modal comparisons. The inter-observer agreement for manual ultrasound measurements (Inter-Observer US) showed excellent consistency, with biases between examiners as low as 17 µm and 24 µm corresponds to 8.5% and 12% error relative to a typical 200 µm bone change increment. A particularly telling result is found in the cross-modal comparisons for each examiner (Ultrasound vs Camera (Manual blind examiners)). For Examiner 2, the bias was minimal of −60 µm corresponds to less than 30% error relative to a typical 200 µm bone change increment with the tightest limits of agreement between −530–410 µm among the three examiners. In contrast, the inter-observer agreement for the photographic ground truth itself (Inter-Observer CA) showed wider variability, with a bias of −127 µm between Examiners 2 and 3 corresponds to less than 63.5% error relative to a typical 200 µm bone change increment. This indicates that a portion of the disagreement between ultrasound and camera can be attributed to the inherent challenges of manual landmark identification in both modalities, rather than to the ultrasound technology alone. An important observation from S1 Table is the comparison among the ultrasound methods themselves. For instance, the DTS-US vs Auto-SVD-US comparison shows a bias of 105 µm corresponds to 52.5% error relative to a typical 200 µm bone change increment, indicating a systematic difference between these two automated techniques. However, the limits of agreement for this comparison between –225 µm to 435 µm are notably tighter than those observed when comparing ultrasound to the camera ground truth. This suggests that while different ultrasound algorithms may produce offset values, they are consistent with each other, reinforcing the internal reliability of the HFUS modality. Detection of bone level changes and diagnostic accuracy The diagnostic performance of the three ultrasound methods was evaluated by calculating sensitivity and specificity for detecting bone loss at each stage, with results summarized in Table 4. 10.1371/journal.pone.0349815.t004Table 4Diagnostic accuracy of ultrasound measurement methods.Measurement MethodSensitivity (%)Specificity (%) Manual-BO-US 7992 DTS-US 10070 Auto-SVD-US 8270 Diagnostic accuracy of ultrasound measurement methods. Sensitivity was calculated for each tooth and bone loss stage, with values ranging from 33% to 100% across methods and stages. The DTS-US Frame method achieved the highest overall sensitivity (100%) for detecting bone loss at all stages across all teeth. The Manual-BO-US method showed more variable performance, with sensitivity ranging from 33% to 100%. The Auto-SVD-US method demonstrated high sensitivity (100%) for most stages, with slightly lower performance at smaller bone loss increments. Specificity was calculated from pairwise comparisons between replicate frames at the baseline stage, representing the ability to correctly identify no bone loss. The Manual-BO-US method showed the highest specificity (92%), followed by DTS-US and Auto-SVD-US of (70%). The minimum detectable change (MDC) was calculated for each method and tooth, as detailed in Table 5. The minimum detectable change (MDC) was calculated based on measurement variability and represents the smallest change that can be detected beyond measurement noise with statistical confidence, typically calculated as 1.96 × √2 × SD. 10.1371/journal.pone.0349815.t005Table 5Detection sensitivity of ultrasound methods at different bone loss increments and determination of the empirical detection threshold of (138 µm).Tooth/Stage DifferenceThe average amount of bone removal between stages determined by photography (µm)Manual-BO-US (%)DTS-US (%)Auto-SVD-US (%)M3/4th −3rd9967100100M3/1st -No loss 138 100 100 100 PM4/4th −3rd16669100100M2/4th −3rd28997100100M3/6th −5th29233100100M3/5th −4th32944100100PM4/3rd −2nd33061100100M3/3rd −2nd40386100100M2/5th −4th43297100100PM4/1st -No loss441100100100PM4/5th −4th598100100100PM4/2nd - 1st606100100100M3/2nd −1st641100100100M2/3rd-2nd78497100100Note: The empirical detection threshold (~138 µm) represents the smallest actual bone loss increment that was consistently detected above the system error threshold across measurement methods. This value differs from the theoretical minimum detectable change (MDC), which is calculated from measurement variability, and instead reflects experimental detection performance. Detection sensitivity of ultrasound methods at different bone loss increments and determination of the empirical detection threshold of (138 µm). Note: The empirical detection threshold (~138 µm) represents the smallest actual bone loss increment that was consistently detected above the system error threshold across measurement methods. This value differs from the theoretical minimum detectable change (MDC), which is calculated from measurement variability, and instead reflects experimental detection performance. Clinically reliable detection threshold The system error, representing the inherent precision of each method, established a fundamental detection limit for alveolar bone loss, ranging from 77 to 113 µm for the ultrasound methods (Table 2), indicating that changes smaller than these thresholds cannot be reliably distinguished from measurement noise. This capability was experimentally confirmed by the consistent detection of a small but real bone loss increment. At the M3/1st – No loss stage, which involved an average bone loss of 138 µm as measured by the photographic ground truth, all three ultrasound methods successfully detected this change with 100% sensitivity (Table 5). Because this amount exceeded the system error of all methods, it represents a practical detection threshold for the HFUS system. The minimum detectable change (MDC) represents a theoretical statistical threshold derived from measurement variability, whereas the 138 µm value represents the empirically observed minimum bone loss increment that was consistently detectable above the system error threshold across methods. Discussion Novelty and Contribution to the field While several previous studies have demonstrated the feasibility of using high-frequency ultrasound for periodontal and peri-implant imaging [13–17], most have focused on visualization and single-time-point measurements of bone levels or bone thickness. The novelty of this study does not lie in demonstrating that ultrasound can image the alveolar bone, but rather in establishing the quantitative measurement performance required for clinical monitoring of periodontal bone loss progression. Specifically, this study quantifies measurement precision, determines the minimum detectable bone loss change, and evaluates the capability of high-frequency ultrasound for longitudinal monitoring of small bone-level changes. This framework shifts the role of HFUS from a purely imaging modality to a quantitative monitoring tool for periodontal disease progression. In periodontal disease management, the detection of progression (i.e., changes over time) is more clinically relevant than the determination of a single absolute bone level. This explains why HFUS, despite limitations in absolute agreement, is particularly well suited as a monitoring tool for longitudinal assessment rather than a replacement for initial radiographic evaluation. Methodological novelty and experimental design In addition, this study addresses an important experimental challenge in ex vivo validation by introducing fiducial steel ball markers to ensure that measurements were obtained from the exact same anatomical location across different bone loss stages, identified by their characteristic ring-down echo in ultrasound images (Figs 1–3). These markers, together with a voice control command on the Vevo system to eliminate vibrations and the use of a hydrogel pad to improve acoustic coupling and image clarity, enabled accurate determination of system error (77–113 µm) and the empirical detection threshold (138 µm), and provided a reliable spatial reference for validating automated measurement methods. Importantly, the novel automated CEJ-based measurement methods particularly the SVD-based approach were subsequently evaluated without relying on the fiducial markers, demonstrating that automated measurements can achieve comparable precision while using clinically relevant anatomical landmarks. This distinction is important because the fiducial markers were used only for experimental validation, whereas clinical measurements would rely on anatomical landmarks such as the cementoenamel junction and the enamel surface. Together, these contributions establish a quantitative framework for evaluating high-frequency ultrasound as a tool for longitudinal periodontal bone loss monitoring. Null hypothesis and study goal The null hypothesis of this study was that high-frequency ultrasound measurements would not differ significantly from photographic reference measurements and would not be capable of detecting small incremental changes in alveolar bone loss. Based on the results demonstrating low system error, strong agreement with photographic measurements, and reliable detection of small bone loss increments, the null hypothesis was rejected. The goal of this study was not to replace radiography for absolute bone level measurement, but to demonstrate that high-frequency ultrasound can detect small longitudinal changes in alveolar bone loss with high precision and a defined detection threshold. Key study questions: precision, accuracy, and detection capability This study addressed three questions: Q1. Does high-frequency ultrasound offer a precise and reliable alternative to radiography for monitoring bone loss? Our systematic evaluation suggests that HFUS is a precise and reliable method for monitoring alveolar bone loss and may serve as a complementary tool to conventional radiographic methods for longitudinal monitoring. The DTS-US method demonstrated the lowest system error of 77 µm and the automated methods performed comparably or superior to manual measurements while being four times faster. The excellent reliability across all methods (ICC = 0.89–0.99) further establishes HFUS as a robust tool for quantitative periodontal assessment. The reproducibility of measurements deserves further examination beyond the summary ICC values. As detailed in Table 3, inter-observer reliability for manual ultrasound measurements (ICC = 0.98, 95% CI [0.97, 0.98]) was notably higher than for manual photographic measurements (ICC = 0.92, 95% CI [0.88, 0.95]). This finding is noteworthy because it suggests that blinded examiners achieved greater consistency when identifying landmarks in ultrasound images than in photographs a result that may initially seem counterintuitive given the perceived complexity of ultrasound interpretation. One explanation is that the hyperechoic bone crest signal in ultrasound provides a more discrete and unambiguous target for caliper placement compared to the photographic view, where soft tissue remnants or surface irregularities may introduce variability in landmark identification. Inter-method reliability among all five measurement methods ranged from ICC = 0.89 to 0.99 across the three teeth (Table 3), with M2 showing the highest agreement (ICC = 0.99, 95% CI [0.991, 0.997]) and M3 the lowest (ICC = 0.89, 95% CI [0.82, 0.95]). The slightly lower agreement at M3 likely reflects the greater number of bone loss stages (six stages) at this tooth, which introduced more cumulative measurement opportunities for divergence. Among the three ultrasound methods alone, reliability ranged from ICC = 0.86 to 0.98, confirming that the manual, semi-automated, and fully automated approaches produce consistent and interchangeable results for tracking bone loss progression. The combination of low system error (Table 2) and consistently high ICC values across all observer and method comparisons provides strong evidence that the HFUS measurement framework is both precise and reproducible two prerequisites for any longitudinal monitoring tool. Q2. How accurate are ultrasound measurements compared to the established ground truth? Ultrasound measurements showed excellent agreement for tracking changes over time, with the Auto-SVD-US method showing the smallest bias of –18 µm corresponds to less than 10% error relative to a typical 200 µm bone change increment. However, a key finding is the distinct performance profile of HFUS: low system error (high precision) for detecting changes, coexisting with wide limits of agreement (lower accuracy) for single, absolute measurements. This discrepancy arises from challenges in manual probe repositioning, landmark identification subjectivity, and speckle noise. This wide range indicates that for any single measurement, the difference between this automated ultrasound method and the photographic standard could be substantial. While absolute measurements may vary due to reference selection, imaging angle, and anatomical variability, the ultrasound measurements demonstrated high precision and repeatability across stages. In periodontal diagnosis, tracking changes over time is often more clinically relevant than a single absolute measurement value. Therefore, the core clinical value of HFUS lies in its superior ability to safely and precisely monitor disease progression rather than providing a single, absolute baseline measurement, supporting its role as a longitudinal monitoring tool for precision periodontal care. Q3. What is the minimum amount of bone loss that HFUS can reliably detect? This study establishes that HFUS can reliably detect bone loss increments as small as 138 µm, a threshold that approaches the system’s lateral resolution limit of 90 µm. This threshold is substantially lower than the 870 µm limit reported for conventional radiography [5], highlighting the potential of HFUS for detecting earlier stages of periodontal disease. These findings demonstrate that high-frequency ultrasound can detect clinically relevant bone loss changes well below the detection limits of conventional radiography, supporting its potential for early periodontal disease monitoring. Conventional radiography was not directly evaluated in this study; therefore, comparisons with radiographic detection limits are based on values reported in the literature and should be interpreted cautiously. Clinical translation and detection performance This performance profile directly informs its clinical application. The technology is exceptionally well-suited for longitudinal monitoring, where the change from a patient’s own baseline is the critical metric. Regarding clinical readiness, our automated methods are the clear candidates for translation. As summarized in Table 6, the DTS-US method, with its highest sensitivity and lowest system error, is the gold standard for longitudinal monitoring in research. The Auto-SVD-US method, with its fully automated workflow and low bias, is the strongest candidate for rapid, high-throughput clinical screening and monitoring. 10.1371/journal.pone.0349815.t006Table 6Comparative summary of alveolar bone loss measurement methods.MethodKey advantageKey limitationBest use caseClinical readiness & rationale Manual-BO-US High specificity (92%); establishes human performance baseline.Time-consuming; high inter-observer variability; highest system error (113 µm).Lab validation; not suitable for routine clinical use.Low: Prohibitively slow and variable for clinical workflow. DTS-US Highest sensitivity (100%); lowest system error (77 µm). Best for detecting minute changes.Requires sequential scans; measures displacement, not absolute level.Gold-standard for longitudinal monitoring in research and high-precision tracking.High (for monitoring): Excellent for tracking change, the core clinical task. Auto-SVD-US Fully automated; fastest; excellent agreement (lowest bias: −18 µm). Slightly lower sensitivity than DTS-US; wide LoA for single measurements. Ideal for rapid, high-throughput clinical screening and monitoring. High: Automated and fast, enabling seamless integration into patient visits. Conventional Radiography Standard of care; provides absolute anatomical baseline.Ionizing radiation; insensitive to early/minor bone-level changes.Initial diagnosis and baseline assessment.Current Standard dental clinic care Comparative summary of alveolar bone loss measurement methods. The sensitivity–specificity trade-off observed across methods (Table 4) has direct implications for clinical decision-making. The DTS-US method achieved 100% sensitivity but 70% specificity, while the Manual-BO-US method showed 79% sensitivity but the highest specificity of 92%. The Auto-SVD-US method occupied a middle ground with 82% sensitivity and 70% specificity. This trade-off must be interpreted in the context of the clinical consequences of each type of error. In periodontal monitoring, a false negative failing to detect real bone loss progression could result in delayed treatment and irreversible tissue destruction, particularly in patients with aggressive or rapidly progressing disease. A false positive incorrectly identifying bone loss where none has occurred would likely trigger additional follow-up imaging or a shorter recall interval, which, while inconvenient, carries no risk of tissue harm and no ionizing radiation burden when using ultrasound. Given this asymmetry, higher sensitivity should generally be prioritized over specificity in a periodontal monitoring context, supporting the use of DTS-US for research-grade precision and Auto-SVD-US for routine clinical screening. For patients where unnecessary intervention carries greater risk or cost, the higher specificity of manual measurement may be preferred. This performance profile, summarized in Table 6, allows clinicians and researchers to select the most appropriate method based on the specific monitoring scenario and the relative tolerance for false-positive versus false-negative outcomes. The detailed stage-by-stage sensitivity data in Table 5 further illustrate this trade-off: while DTS-US and Auto-SVD-US detected all bone loss stages including the smallest increment of 138 µm, Manual-BO-US sensitivity dropped to 33–44% at certain stages (M3/6th–5th and M3/5th–4th), indicating that manual measurement may miss subtle changes even when cumulative bone loss is substantial. The empirical detection limit of 138 µm for our HFUS system has profound implications. This limit was slightly higher than the system error range (77–113 µm), which is expected because a true detectable change must exceed the inherent measurement noise of the system. This relationship confirms the internal consistency of the measurement performance analysis and supports the validity of the experimentally determined detection threshold. For longitudinal monitoring, the empirical detection threshold is more clinically meaningful because it reflects the real detection performance of the system rather than a purely statistical estimate. Due to the limited number of independent bone-loss events evaluated in this proof-of-concept study, confidence intervals for sensitivity and specificity would be wide and therefore less precise. Accordingly, these estimates should be interpreted with caution and considered preliminary indicators of detection performance rather than definitive measures of diagnostic accuracy. Agreement analysis and the role of precision versus accuracy The regression analyses demonstrated moderate correlation coefficients (R² ≈ 0.41–0.55) between ultrasound measurements and the photographic ground truth. While these values are statistically significant, they indicate only moderate linear association and reflect variability in measurement dispersion rather than direct agreement between methods. Importantly, R² quantifies the strength of correlation but does not assess measurement agreement or interchangeability. Despite the moderate R² values, the relatively low mean bias observed in the Bland–Altman analysis indicates that systematic error is limited and that the primary source of variability arises from random measurement scatter rather than consistent over- or underestimation. Ultrasound measurements did not consistently overestimate or underestimate bone levels but instead showed variability around the reference measurements. This distinction explains how moderate correlation can coexist with low bias. The limits of agreement observed in the Bland–Altman analysis indicate that ultrasound measurements should not be considered interchangeable with photographic reference measurements for absolute bone level determination. However, periodontal disease management is primarily concerned with detecting changes in bone levels over time rather than determining a single absolute measurement. In this context, the low system error (77–113 µm) and the small empirical detection threshold (~138 µm) demonstrate high precision in detecting longitudinal changes above the measurement noise floor. Therefore, the ability of high-frequency ultrasound to detect small changes relative to baseline with low systematic bias is more clinically relevant than achieving high absolute agreement with a reference method. These findings highlight an important distinction between accuracy and precision: while absolute measurements show variability, the system demonstrates high precision for monitoring change over time. Overall, high-frequency ultrasound is best positioned as a longitudinal monitoring tool for tracking small changes in alveolar bone levels, rather than serving as a direct replacement for radiographic methods used for absolute measurements or initial diagnosis. The limits of agreement (approximately 700–800 µm) are substantially larger than the empirically determined detection threshold (~138 µm), indicating that while absolute measurements exhibit considerable variability, the system retains high sensitivity for detecting small longitudinal changes above the noise floor. Importantly, clinically meaningful changes in periodontal bone levels are typically on the order of 100–200 µm in longitudinal monitoring, indicating that the detection threshold of ~138 µm falls within this clinically relevant range. This disparity highlights an important distinction between absolute accuracy and changes detection capability. The relatively wide limits of agreement reflect variability in single-time-point measurements and therefore limit the use of HFUS for precise absolute bone level determination. However, the much smaller detection threshold demonstrates that the system is capable of consistently identifying clinically relevant incremental changes over time. From a clinical perspective, periodontal disease monitoring primarily relies on detecting progression rather than establishing a single absolute bone level measurement. Importantly, clinical decision-making relies on reproducible quantitative measurements rather than visual estimation alone. While photographic reference images may appear visually precise, clinicians cannot directly measure bone levels by visual inspection, and therefore consistent detection of changes over time is more clinically meaningful than strict agreement with a reference image. In this context, the ability to reliably detect changes exceeding the system error threshold is more meaningful than achieving tight agreement with a reference method. Therefore, despite the wide limits of agreement, the measurement characteristics of HFUS support its role as a longitudinal monitoring tool, where relative changes from baseline are of primary importance. Study strengths A major strength of this study is the use of a controlled ex vivo model with incremental bone removal and precise photographic ground truth measurements, which allowed accurate quantification of system error, agreement, and minimum detectable change. In addition, multiple measurement approaches were evaluated, including manual, semi-automated, and fully automated ultrasound methods, providing a comprehensive comparison of performance, reliability, and measurement precision across different analysis strategies. The study design incorporated repeated measurements, blinded observers, and automated algorithms, enabling robust evaluation of reliability, agreement, and detection performance. Importantly, this study focused not only on measurement accuracy but also on system error, minimum detectable change, and empirical detection thresholds, which are clinically relevant parameters for longitudinal monitoring. This controlled experimental design enabled a systematic evaluation of the performance characteristics of high-frequency ultrasound for detecting and monitoring small longitudinal changes in alveolar bone loss. Anatomical considerations and prior work Previous studies using high-frequency ultrasound for periodontal imaging have demonstrated that ultrasound can identify key anatomical landmarks such as the cementoenamel junction, gingival margin, and alveolar bone crest in both extracted jaws and human subjects [25]. These findings suggest that ultrasound imaging can be applied to periodontal structures beyond simple geometries. However, complex anatomical regions such as interdental spaces and furcation areas may present challenges related to probe positioning, beam angle, acoustic shadowing, and transducer access. Imaging in posterior teeth and complex periodontal defects may therefore require improved probe positioning strategies and the development of dedicated intraoral ultrasound transducers optimized for periodontal imaging. To date, emerging studies have begun to address these experimental challenges [41]. Automated SVD-based measurement method In this study, the Auto-SVD-US method was developed to measure alveolar bone loss by leveraging multi-frame compounding and noise suppression to generate a high-fidelity representative image for each examination time point. The core innovation of this method is the use of Singular Value Decomposition (SVD) [34,35] to create a single, enhanced image from multiple approximately acquired frames, thereby mitigating the confounding effects of micro-shaking and speckle noise inherent in clinical ultrasound scanning. This approach addresses a fundamental challenge in longitudinal ultrasound analysis: the inability to achieve perfect probe repositioning, which introduces measurement artifacts that render conventional pairwise frame comparisons noisy and unreliable. By shifting the paradigm from multiple comparisons of raw data to a single, precise comparison between SVD-enhanced consensus images, the method ensures that subtle yet critical changes in bone topography can be detected with superior accuracy and efficiency, providing a stable foundation for tracking periodontal disease progression. A pertinent question that arises in automated image analysis is how the algorithm ensures specificity in identifying true anatomical landmarks amidst ubiquitous image gradients and speckle noise. Our methodology addresses this through a multi-layered processing pipeline, not a simple peak-detection search. The core of this strategy is the application of Singular Value Decomposition (SVD) filtering, which acts as an anatomical clutter filter by preserving only the dominant signal components corresponding to coherent tissue interfaces while suppressing higher-order noise. Furthermore, the search for landmarks like the alveolar bone crest is constrained to anatomically plausible regions defined by the initial CEJ location and the traced enamel surface, effectively ignoring most confounding gradients. Regarding the geometrical definition of bone loss, the algorithm quantifies the CEJ-to-ABC distance based on clinical convention. We deliberately implemented a longitudinal measurement to align with the standard clinical attachment level recorded in periodontal practice, ensuring the output is directly interpretable and relevant for clinical decision-making. This focus on replicating established clinical metrics, combined with advanced signal processing to ensure specificity, was crucial for validating this proof-of-concept tool against the photographic ground truth. The diagnostic performance analysis was based on a limited number of independent bone loss events, which may result in wide confidence intervals for sensitivity and specificity estimates. Therefore, these values should be interpreted as preliminary and require validation in larger experimental and clinical studies. Comparison with other imaging modalities A fundamental consideration in any imaging modality is the trade-off between resolution and soft-tissue penetration. While laboratory tools like optical interferometers [42,43] and optical coherence tomography (OCT) [44–46] provide superior axial resolution (sub-micron and ~4 µm, respectively), they cannot image through the gingiva, rendering them unsuitable for non-invasive clinical bone assessment. Conversely, CBCT provides 3D volumetric data but at a lower resolution (±100–200 µm) and with the significant drawback of ionizing radiation. Within this landscape, high-frequency ultrasound (HFUS) was selected for its unique ability to balance sufficient resolution (axial precision ±50 µm) with the necessary penetration to image through soft tissue to the underlying bone. This specific capability is a prerequisite for a clinically viable, non-ionizing tool for periodontal monitoring. The demonstrated 138 µm detection threshold, which is remarkably close to the system’s lateral resolution limit of 90 µm, demonstrates the ability of HFUS to detect subtle bone-level changes and fills an important diagnostic gap for early, active disease monitoring. Clinical implications and workflow integration In summary, the statistical analyses in this study follow a deliberate logical progression: from characterizing the measurement noise floor through system error (Table 2), to establishing detection capability through the empirical threshold of 138 µm and sensitivity/specificity analysis (Tables 4 and 5), to validating agreement and reliability through Bland–Altman analysis (Fig. 4, S1 Table) and ICC assessment (Table 3), and finally to confirming correlation through regression analysis (Fig. 4d). This progression demonstrates that the clinical value of HFUS for periodontal monitoring rests not on absolute measurement accuracy where the wide limits of agreement (676–844 µm range) indicate that single measurements should not be considered interchangeable with photographic references but on measurement precision, where the low system error (77–113 µm) and empirical detection threshold of (138 µm) enable detection of longitudinal changes approximately six times smaller than the 870 µm threshold reported for conventional radiography. The core clinical insight is that periodontal disease management depends on detecting changes from a patient’s own baseline over time, not on a single absolute bone-level value. The HFUS framework established in this study particularly through the automated DTS-US and Auto-SVD-US workflows provides the precision, reliability, and detection sensitivity required for this task, while eliminating ionizing radiation exposure and enabling more frequent monitoring intervals. This quantitative framework shifts the role of HFUS from a purely imaging modality to a validated measurement tool for longitudinal periodontal bone loss monitoring. This study establishes that HFUS, particularly via automated algorithms, enables reliable, radiation-free quantification of alveolar bone loss with a sub-millimeter detection capability. Its optimal clinical application is in the safe, repetitive monitoring of disease progression, facilitating a shift from reactive to proactive periodontal care. In a potential clinical workflow, ultrasound acquisition at a single periodontal site requires approximately 10–20 seconds, and operator training primarily involves probe positioning and CEJ identification. With automated processing, the workflow could be integrated into routine periodontal monitoring visits. Importantly, the detection threshold (~138 µm) lies well below the limits of agreement, reinforcing that the system can detect meaningful changes even in the presence of variability in absolute measurements. Limitations This study has several limitations. First, the experiments were performed using an ex vivo swine jaw model without soft tissue inflammation or physiological conditions, which may differ from in vivo imaging conditions and may not fully represent inflammatory bone resorption seen in periodontitis. Specifically, we now state that the study was conducted on multiple teeth within a single porcine mandible, with measurements performed across controlled bone-loss stages. We further clarify that, although multiple teeth, stages, and repeated measurements were included, these observations do not represent independent biological samples and should be interpreted within a repeated-measurement framework. The potential for pseudoreplication is now explicitly acknowledged. While this design enables detailed evaluation of measurement performance, it does not capture biological variation between different animals. However, this study was designed as a proof-of-concept validation of measurement performance under controlled conditions, and the measurement framework and methodology remain applicable across conditions. The specimen was selected by convenience sampling based on availability, intact anatomy, and suitability for controlled defect creation. This limits the generalizability of the findings to broader biological variation, different tooth types, different ages, and clinical periodontal conditions. No experimental randomization was performed for specimen selection or defect creation. The randomization used in this study applied only to the blinded image-evaluation process, where images were anonymized and presented in random order to reduce observer bias. Formal normality testing was not performed for all statistical comparisons due to the limited number of independent experimental units. Baseline error distributions were visually inspected and appeared approximately normally distributed. Therefore, ANOVA- and ICC-based results should be interpreted as measures of internal consistency and reliability within this controlled repeated-measurement framework rather than as population-level inference. Confidence intervals for sensitivity and specificity are inherently limited by the small number of independent bone-loss events in this proof-of-concept study and may therefore be wide and less reliable. Accordingly, sensitivity and specificity values should be interpreted as preliminary estimates of detection performance rather than definitive diagnostic accuracy metrics. No acquired datasets, images, or measurements were excluded from the analysis, and no data loss occurred. Second, alveolar bone defects were created using controlled mechanical removal rather than inflammatory bone resorption, which may result in different bone surface morphology compared to clinical bone loss patterns. Third, the study was performed under controlled experimental conditions with careful probe positioning and alignment, which may differ from clinical scanning conditions where operator variability, saliva, soft tissue thickness, and patient movement may influence image quality and measurement accuracy. Fourth, steel ball fiducial markers were used only in the ex vivo model to establish precise ground truth reference measurements and frame alignment. These markers are not clinically applicable; however, the automated measurement method developed in this study uses the cementoenamel junction (CEJ) as a natural anatomical reference point, which is clinically applicable and eliminates the need for fiducial markers. Finally, although this study demonstrates measurement precision and detection capability of high-frequency ultrasound, further in vivo studies and clinical trials are required to evaluate clinical performance, reproducibility, and workflow integration. Despite these limitations, this study establishes a quantitative framework for evaluating measurement precision, system error, and minimum detectable change for longitudinal monitoring of alveolar bone loss using high-frequency ultrasound. In addition, the number of independent bone loss events used for diagnostic performance analysis was limited, and therefore sensitivity and specificity estimates should be interpreted as preliminary. Conclusion This proof-of-concept study demonstrated that high-frequency ultrasound can quantify alveolar bone loss with low system error, strong agreement with photographic measurements, and the ability to detect small incremental changes of approximately 138 µm. These results indicate that high-frequency ultrasound is particularly suitable for longitudinal monitoring of alveolar bone loss progression rather than for single absolute measurements. The automated ultrasound methods showed high reliability and measurement consistency, supporting their potential for future clinical monitoring applications. It should be noted that conventional radiography was not directly evaluated in this study; therefore, comparisons with radiographic detection limits are based on previously published literature and should be interpreted with caution. The present study demonstrates the measurement precision and detection capability of HFUS in a controlled experimental model rather than direct clinical diagnostic superiority. High-frequency ultrasound should therefore be considered a tool for longitudinal monitoring of periodontal bone loss progression rather than a replacement for radiographic assessment of absolute bone levels. Supporting information Comprehensive Bland–Altman agreement statistics. (PDF) Alveolar Bone Loss Analysis MATLAB GUI Code. (PDF) Post hoc statistical power analysis. (PDF) 16 Feb 2026 -->PONE-D-26-02614-->-->Quantification of Alveolar Bone Loss Using High-Frequency Ultrasonography for Precision Periodontal Monitoring-->-->PLOS One Dear Dr. Jokerst, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.-->--> -->-->Please find our external Reviewers' comments and recommendations forwarded below. You will see that the full spectrum of final decisions ranges from 'minor revisions' to 'rejection', so please revise your draft carefully but thoroughly, and re-submit an elaborated response sticking to each and every comment given below. Please remember that one review is considered standard, and that revised drafts not considered satisfying must lead to 'outright reject'. Please submit your revised manuscript by Apr 02 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:--> A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Prof. Dr. Dr. h. c. Andrej M Kielbassa Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please note that PLOS One has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. Please update your submission to use the PLOS LaTeX template. The template and more information on our requirements for LaTeX submissions can be found at http://journals.plos.org/plosone/s/latex. 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: “This research was funded by the National Institute of Dental and Craniofacial Research (NIDCR) grant number R01DE031561.” We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “This work was supported by the National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health (NIH), grant R01DE031561, awarded to J.V.J. and C.C. (https://www.nidcr.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 6. Please include a separate caption for each figure in your manuscript. 7. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files 8. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 9. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Partly Reviewer #5: Yes Reviewer #6: Yes ********** -->2. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: No Reviewer #2: I Don't Know Reviewer #3: No Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes ********** -->3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes ********** -->4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes ********** -->5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: Title - "Quantification of Alveolar Bone Loss Using High-Frequency Ultrasonography for Precision Periodontal Monitoring" - please stick to Plos One's Guidelines for Authors at https://journals.plos.org/plosone/s/submission-guidelines. No capital letters. - Please provide type of study. Abstract - With your current 174 words, you do not provide sufficient information. Please stick to the 300-word count allowed for with this section. - Provide sound methodology, and stick to exact results, along with exact P values- - With your Conclusions, please stick exclusively to your aims. Do not simply repeat your results here. Do not speculate. Do not provide well-accepted (but meaningless) phrases. Instead, provide a reasonable and generalizable extension of your outcome. Intro - Your "Clinical Relevance/Background:" does not stick to Journal style. Please consult some recently published Plos One papers, and revise carefully. - Same with "Added Value of This Study:" and "Clinical Implications:". - Same with your references. "(...) change for detection ¹." must read "(...) change for detection [1]." - Same with "1. INTRODUCTION". Again, stick to the Journal's guidelines, and consult some recently published Plos One papers. Revise carefully, but thoroughly. - Please provide a sound null hypothesis. Meths - Again, please compare "2. Materials and Methods", and revise for uniform Journal style. - With ALL materials (including chemicals) and methodologies (including statistical software), please use general/non-proprietary names with your text, followed by (brand name; manufacturer, city, ST[ate - abbreviated, if US], country) in parentheses. Stick to semicolon. Ensure reproducibility, and revise thoroughly. - "h (height) x w (width)" must read "h (height) × w (width)". Please use symbol × instead of letter x. Revise thoroughly throughout your text. Results - With your P values, please stick to Journal style. Disc - What about H0? - "Our systematic evaluation confirms that HFUS is a precise and reliable alternative." Alternative to what? - What about the strengths of your study? - What about the limitations? - Please provide sound responses to your teaching objectives. Concl - Again, with your Conclusions, please stick exclusively to your aims. Do not simply repeat your results here. Do not speculate. Do not provide well-accepted (but meaningless) phrases. Instead, provide a reasonable and generalizable extension of your outcome. Refs - Revise for sound and uniform Journal style. Again, stick to Authors' Guidelines. In total, this draft would seem interesting, but would not seem ready to proceed. Sticking to the Journal's guidelines would seem mandatory. Please remember that Authors (but neither Reviewers nor Editors or Typesetters)) are responsible for sound drafts, and note that one review is considered standard. Reviewer #2: This study is fundamental research toward quantifying alveolar bone resorption using high-frequency ultrasound. As stated in the conclusion, it holds the potential to revolutionize future periodontal disease diagnosis. Specifically, conventional diagnosis using two-dimensional images from X-rays primarily detects alveolar bone resorption centered on the mesio-distal regions of teeth where the root and alveolar bone do not overlap. This study demonstrates results enabling effective detection of alveolar bone resorption in the buccal and lingual central regions, areas where early bone resorption is difficult to detect. However, considering actual clinical settings, challenges remain for the practical implementation of alveolar bone resorption detection using this system. 1. Reference markers were fixed into drilled holes using cyanoacrylate adhesive (Gorilla Glue/Super Glue) and positioned as reference markers 3-4mm above the initial alveolar bone level on teeth M3, M2, and PM4. However, on M3, M2, and PM4, where exactly on the buccal side (mesial, central, or distal) were these markers placed? Furthermore, this reference 20 does not appear to be an appropriate citation. 2. Related to the above point, when the current analysis site has a relatively simple morphology, it raises the question of whether high-frequency ultrasound can detect bone resorption within complex three-dimensional periodontal structures, such as adjacent interdental spaces and furcations, which are common sites for periodontitis. 3. Inflammatory bone resorption due to periodontitis dissolves the superficial cortical bone and causes complex changes in the structure of the cancellous bone. The alveolar bone resorption induced in this study resulted from artificial bone removal using a chisel. It is possible that this method may not adequately reflect the marginal bone loss caused by alveolar bone resorption associated with actual soft tissue inflammation, particularly at the bone margin. For instance, an analysis using experimental periodontitis in animal models would provide a more realistic analytical model reflecting actual alveolar bone resorption. Therefore, it would be ideal if the validity of the findings could be assessed in such a model. 4. The limitations of this study are not mentioned in the final section of the discussion. For this model to be effectively applied in clinical practice, there must be outstanding issues that must be overcome. Reviewer #3: Dear authors, I evaluated the article titled “Quantification of Alveolar Bone Loss Using High-Frequency Ultrasonography for Precision Periodontal Monitoring.” The goal was "to establish its system error, detection capability, and agreement with a photographic ground truth." This is an interesting study! Therefore, some concerns were raised. A concern was raised: is there necessity/justification for this proof of concept study? The justification presented by the authors was robust. They have successfully addressed the "Goldilocks" zone of periodontal imaging: (1) resolution: it was demonstrated a detection threshold (~138 μm) that is nearly 6x more sensitive than traditional radiography (~870 μm); (2) safety: it removed the ionizing radiation barrier, allowing for the "repetitive monitoring" that is currently impossible with CBCT; and (3) automation: by using SVD-filtering and automated CEJ-tracking, you address the primary criticism of ultrasound: operator subjectivity. Revised Article - per section 1. Title: I suggest a modification… recommended: Sub-Millimeter Quantification of Alveolar Bone Loss using Automated 40 MHz High-Frequency Ultrasound: A Proof-of-Concept Study. Please check it 2. Abstract: it was condensed and with high-impact 3. Keywords: I suggest to include at least one of the following: "Precision Medicine," "Non-ionizing Radiation," or "Digital Dentistry" 4. Introduction: - Ensure you emphasize that periodontitis is a dynamic disease, but our current tools (radiography) are static and insensitive. - "The 'diagnostic window' for early intervention is frequently missed because conventional radiographs require a 30-50% mineral loss before a defect becomes visible. This study introduces a 40 MHz HFUS workflow that bridges this gap by offering a theoretical axial resolution of 40 μm." - “Periodontitis is one of the two leading diseases in dentistry, along with dental caries 2,3 resulting in pain, tooth loss 4, diminished quality of life5, and possible systemic effects such as Type II diabetes 6 and cardiovascular disease7. In patients suffering from periodontitis, bacteria-induced inflammatory responses destroy soft and hard tissues supporting the teeth (i.e., the periodontium)8.” WHY 8 references in the first paragraph? Reduce it for 3. 5. MM: it is necessary a structural refinement: - The SVD innovation: the authors must explicitly state why SVD was used. It wasn't just for "noise reduction" – it was to extract the coherent topographic signal from the "clutter" of speckle noise. - Mathematical notation: Ensure your SVD equation A=UΣVT is clearly defined as the "economy-size" decomposition to show computational efficiency. 6. Results & Discussion: - In your discussion, you must address the "Precision vs. Accuracy" paradox you found: Precision (high): excellent for tracking change over time; Accuracy (variable): Challenging for single absolute measurements. - The pitch: argue that in periodontology, progression (delta) is more clinically significant than a single baseline value. This justifies why HFUS is the perfect "monitoring" tool even if it doesn't replace the initial radiographic survey. Key Revisions Checklist for Top-Tier Submission Statistical rigor: Ensure Table A1 (Bland-Altman) includes Proportion of Bias. If the bias is only -18 μm on a 200 μm change, that is a <10% error – a huge selling point. - Explicitly mention that Method 2 (Auto-SVD) removes the need for fiducial markers (steel balls), making it the "clinically viable" path. 7. References: due to the topic studied, ensure you cite recent (2023-2025) AI-segmentation papers to show how your SVD approach complements current trends. Reviewer #4: High frequency ultrasonography (HFUS) for alveolar bone loss is an emerging, non-invasive imaging technique being explored as an alternative or adjunct to radiographs in periodontal diagnosis. It allows real-time visualization of the alveolar crest, buccal bone thickness, and soft tissues without radiation. HFUS for periodontal and peri-implant bone assessment has been actively researched by several ex vivo and clinical studies. The preclinical diagnostic accuracy studies have already showed good agreement between HFUS and imaging for crestal bone thickness and alveolar bone distance measurements repeatedly. While this study is well executed, it does not provide sufficient novelty or significance to the diagnosis of periodontal or peri-implant diseases. Larger, standardized clinical trials are needed to fully validate diagnostic thresholds and automated measurement software. Reviewer #5: The manuscript is scientifically sound and methodologically robust. The ex vivo model is appropriate for a proof-of-concept study, and the authors apply multiple complementary measurement strategies, which strengthens internal validity. My main concern relates to interpretative balance. The detection capability is promising. However, the limits of agreement reported in the Bland–Altman analyses are relatively wide, suggesting that the technology may be better suited for longitudinal monitoring of changes over time rather than direct substitution of photographic reference methods for absolute measurements. This distinction should be stated more explicitly in the Discussion. Overall, the manuscript meets the journal’s standards for methodological rigor. The requested revisions aim to improve clarity and transparency rather than address fundamental flaws. 1. Clear differentiation of statistical concepts: system error, minimum detectable change, and empirical detection threshold. In the Methods (pp. 16–17) and Results (p. 20), the manuscript introduces multiple related statistical metrics: System error (Mean + 2SD of baseline), minimum detectable change, empirical detection threshold (~138 µm). While each appears methodologically justified, the distinctions between these concepts are not fully explicit. This may lead to interpretative ambiguity. Please: Provide clear definitions of each metric. Explain how they relate conceptually. Clarify which metric should be interpreted as the clinically meaningful threshold for longitudinal monitoring. Explicitly state whether the minimum detectable change was calculated using the conventional formula (e.g., 1.96 × √2 × SD) or whether the threshold reported is purely empirical. A clearer statistical framework will substantially improve transparency. 2. Interpretation of regression analyses (R² values) In the regression analyses comparing ultrasound-based measurements with photographic ground truth (p. 18), R² values range approximately between 0.41 and 0.55. Although statistically significant, these values indicate moderate correlation. Please expand the discussion to address: The methodological meaning of these coefficients. How moderate R² values should be interpreted in light of low mean bias. Whether these correlation levels support clinical interchangeability or rather reinforce the role of HFUS as a longitudinal monitoring tool. The manuscript would benefit from a more explicit and balanced interpretation of these findings. 3. Clinical implications of Bland–Altman limits of agreement The Bland–Altman analyses (p. 19) demonstrate limits of agreement approaching approximately 700–800 µm in certain comparisons. While acknowledged, the clinical implications of these intervals require clearer contextualization. Please: Discuss whether these intervals allow true interchangeability with photographic reference measurements. Explicitly differentiate between suitability for absolute measurement and suitability for change detection over time. Clarify how these limits compare to clinically meaningful thresholds in periodontal assessment. This distinction is essential for appropriate interpretation. 4. Algorithm transparency and reproducibility The Auto-SVD-US method (pp. 13–16) is described in detail, which is commendable. To enhance reproducibility: Clearly specify which algorithm parameters are fixed and which are user-defined. Indicate whether the implementation code (e.g., MATLAB scripts) or pseudocode will be made available. If parameter tuning was performed, describe the selection process. This will strengthen methodological transparency. 5. Justification of the Mean + 2SD threshold Please indicate whether baseline data distribution was tested for normality before defining system error as Mean + 2SD. If tested, briefly describe the method used. 6. Expansion of limitations regarding the ex vivo model Although the experimental model is well described (pp. 10–12), please expand the Discussion to briefly address additional in vivo considerations such as: Soft tissue variability Saliva presence Probe angulation variability Differences in acoustic impedance in clinical conditions. 7. Translational integration into clinical workflow Consider adding a brief statement regarding: Estimated acquisition time per site Operator training requirements Practical considerations for clinical implementation Reviewer #6: Thank you for the opportunity to review the manuscript submitted under the title “Quantification of Alveolar Bone Loss Using High-Frequency Ultrasonography for Precision Periodontal Monitoring.” Below, I present my impressions derived from a careful reading of the text, outlining my interpretations and, where appropriate, offering recommendations for the authors’ consideration. Regarding the title The submitted article title employs clear, elegant, and technically accurate language, appropriately highlighting the central technology (HFUS) and the clinical context of periodontal monitoring with increased precision, while remaining concise. However, some limitations warrant reflection. The title may be overly generic for an experimental validation study, omitting essential information for experienced readers and methodological reviewers (such as the sample, comparator, and study design). As a result, it does not fully convey the originality or experimental rigor of the work. Regarding the introduction and objectives Overall, the research rationale and literature exploration are adequate and well substantiated, with a clear logical progression and consistent use of references to support the scientific problem. Suggestion for improvement: Although the literature is well explored, the introduction could benefit from an explicit sentence comparing HFUS with previous attempts at periodontal ultrasonography, even if only to highlight their limitations (e.g., insufficient frequency, low resolution, lack of quantitative validation). This would further strengthen the originality of the study. The relevance and contribution of the study are, in general, very well-articulated, both from clinical and technological perspectives, clearly justifying the need for publication. The formulation and adequacy of the objectives are clear and methodologically aligned with the stated rationale. Regarding the methods A high level of coherence was observed between the introduction, objectives, and the methods presented, with no misalignment between the research question, experimental design, and statistical strategy. A formal sample size calculation is lacking. It should be noted that the use of a single mandible, in which three teeth were evaluated across ten stages of bone loss, does not increase the sample size, although the large number of measurements enhances result precision, improves estimation of systematic error, and increases intra- and interobserver confidence. In light of this, I recommend explicitly stating that no sample size calculation was performed, justifying this decision based on the methodological nature of the study and its emphasis on system error and agreement. It would also be advisable to report inherent study limitations, including convenience sampling and the absence of randomization. I further suggest explicitly structuring eligibility criteria (inclusion/exclusion) in a dedicated subsection, even in an ex vivo study. The identification of variables was appropriate and consistent with the objectives. The explicit use of the cementoenamel junction as the anatomical reference for measurements is commendable, as it enhances clinical relevance. Regarding statistics after completion of the experiment I recommend justifying the absence of normality tests or, if applicable, stating that normality was assumed based on graphical inspection (e.g., histograms, Q–Q plots). The hypothesis testing was based on system error, agreement (Bland–Altman), reliability (ICC), and diagnostic testing (accuracy/sensitivity/specificity), which is consistent with method validation studies. With respect to diagnostic testing, I noted the following limitations that should be acknowledged: a small number of independent events and the absence of confidence intervals for sensitivity and specificity. In this context, I recommend reporting 95% confidence intervals, even if they are wide. These statistical limitations do not invalidate the results; however, readers should be reminded that external clinical validation has not yet been performed (even if this is implicitly understood). Regarding the results There is coherence between the reported results and the variables previously defined in the methods, with no outcomes presented that are unrelated to the methodological framework or not anticipated in the analytical plan. A clear consistency exists between the scientific question, variable types, statistical tests, and the reported results. To improve methodological quality and reduce the risk of bias, I recommend explicitly stating whether any data losses or exclusions occurred during the study. As a point for reflection, a degree of undue extrapolation was perceived in the reporting of results, introducing a mild rhetorical risk in comparisons with conventional radiography. This could likely be mitigated through more careful contextual qualification. Regarding the discussion The discussion is technically sound, coherent with the results, transparent regarding limitations, and well-grounded in physical, statistical, and clinical principles. It could be improved by tempering indirect comparisons with radiography, moderating occasionally emphatic language, and reinforcing the experimental/ex vivo nature of the study. Regarding the conclusion The conclusion is largely coherent with the research objectives and is based on results obtained using the proposed methodology. However, conceptual issues arise from indirect comparisons based on the literature (radiography ≠ HFUS). Conventional radiography was not tested in the present study, and although this comparison is appropriately qualified in the main text, the conclusion does not reiterate this caution. Regarding the references The references are well selected and appropriate to the development of the study. Nevertheless, I suggest updating them to include more recent articles, at least up to 2025, and revising their formatting and spelling in accordance with the journal’s reference style guidelines and reference type requirements. ********** -->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: No Reviewer #5: No Reviewer #6: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. 13 Apr 2026 Subject: Revised Manuscript Submission – PONE-D-26-02614 Dear Prof. Kielbassa, Thank you for the opportunity to revise and resubmit our manuscript (PONE-D-26-02614). We have carefully revised the manuscript according to the reviewers’ and editor’s comments and have addressed each comment in detail in the response-to-reviewers document. The revised submission includes: 1. Response to Reviewers 2. Revised Manuscript with Track Changes 3. Clean Manuscript 4. Updated Figures and Captions 5. Supporting Information files 6. Updated Funding Statement and Data Availability information We appreciate the reviewers’ constructive feedback, which has significantly improved the manuscript. We hope the revised version is now suitable for publication in PLOS ONE. Sincerely, Jesse V. Jokerst Submitted filename: Response to Reviewers_Final.docx 20 Apr 2026 -->PONE-D-26-02614R1-->-->Sub-millimeter quantification of alveolar bone loss using automated 40 MHz high-frequency ultrasound: a proof-of-concept ex vivo validation study-->-->PLOS One Dear Dr. Jokerst, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but still does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.--> Please note that (while several Referees have been satisfied with your re-submitted draft) one of our external Reviewers has indicated that still some minor aspects would seem perfectible.I just have double checked those comments, and your surely will agree that the latter are justified. Please note that (while several Referees have been satisfied with your re-submitted draft) one of our external Reviewers has indicated that still some minor aspects would seem perfectible. Please note that (while several Referees have been satisfied with your re-submitted draft) one of our external Reviewers has indicated that still some minor aspects would seem perfectible. I just have double checked those comments, and your surely will agree that the latter are justified. I just have double checked those comments, and your surely will agree that the latter are justified. Please submit your revised manuscript by Jun 04 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. --> If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Andrej M Kielbassa Academic Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--> Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed Reviewer #5: All comments have been addressed Reviewer #6: (No Response) ********** -->2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Yes Reviewer #2: (No Response) Reviewer #3: Yes Reviewer #5: Yes Reviewer #6: Partly ********** -->3. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: Yes Reviewer #2: (No Response) Reviewer #3: Yes Reviewer #5: Yes Reviewer #6: No ********** -->4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: (No Response) Reviewer #3: Yes Reviewer #5: Yes Reviewer #6: Yes ********** -->5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: (No Response) Reviewer #3: Yes Reviewer #5: Yes Reviewer #6: Yes ********** -->6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: With the help of the previous Reviewers' comments and recommendations, this revised and re-submitted draft could be considerably improved. Should be ready to proceed now. Congrats, and stay healthy! Reviewer #2: (No Response) Reviewer #3: Dear authors, Thank you so much for all the revision and new version of your article. I have no further comments or questions. Best regards. Reviewer #5: (No Response) Reviewer #6: I thank the authors for their careful review of the manuscript. The updated version presents clear improvements in structure, greater clarity, and alignment between objectives, methods, and results. The manuscript now presents a more balanced and technically sound discussion, and the overall scientific contribution is evident. However, some important methodological limitations remain insufficiently addressed or not explicitly stated, compromising the transparency of the study. Given the proof-of-concept and ex vivo nature of the work, these issues do not invalidate the conclusions, but should be clearly acknowledged to ensure proper interpretation by clinical readers and researchers who wish to use this reference for further study. I strongly recommend, in the interest of a more transparent scientific method, that the authors explicitly include the following points in the limitations section (within the Discussion section): The use of a single specimen (n=1), clarifying that repeated measurements do not increase the number of independent samples (pseudoreplication). The convenience sampling approach and its implications for generalization. The absence of experimental randomization, differentiating it from the randomization used for blind image evaluation. A justification for the absence of normality tests or clarification of any assumptions made (especially relevant for ANOVA/ICC-based analyses). The absence of confidence intervals (e.g., 95%) for sensitivity and specificity, especially considering the limited number of independent events. A clear statement about exclusions or data loss, even if none occurred. These additions are relatively small from a structural point of view, but are essential for methodological transparency and adherence to good reporting practices. Final recommendation: Accept after minor revisions. ********** -->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Gustavo Fernandes Reviewer #5: No Reviewer #6: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. --> 2 May 2026 (Note: this section will be repeated again at this combined PDF file with a font color as the attachment "Response to Reviewers" , but it is mandatory to be pasted here as a required information at the journal submission "Comments" ) Response to Reviewers RESEARCH ARTICLE Sub-Millimeter Quantification of Alveolar Bone Loss Using Automated 40 MHz High-Frequency Ultrasound: A Proof-of-Concept Ex Vivo Validation Study Tamer Abdelrehim1, Baiyan Qi1, Bryant Tran2, Mirali Pandya3, Jesse V. Jokerst*1,3,4, Casey Chen*2 1 Aiiso Yufeng Li Family Department of Chemical and NanoEngineering, University of California San Diego, La Jolla, California, United States of America, 2 Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, California, United States of America, 3 Materials Science and Engineering Program, University of California San Diego, La Jolla, California, United States of America, 4 Department of Radiology, University of California San Diego, La Jolla, California, United States of America * ccchen@usc.edu, jjokerst@ucsd.edu We would like to thank the academic editor and the reviewers for their previous careful evaluation of our manuscript and for their constructive and insightful comments. We have revised the manuscript thoroughly according to the reviewers’ suggestions. We believe that these revisions have significantly more improved the clarity, structure, and scientific presentation of the manuscript. Below we provide a detailed, point-by-point response to each reviewer comment. All changes have been incorporated into the revised manuscript and are indicated in the tracked changes version. Reviewer comment: with bold black. Author Response: with regular black. New text edited at the manuscript: with regular blue Reviewer #1: With the help of the previous Reviewers' comments and recommendations, this revised and re-submitted draft could be considerably improved. Should be ready to proceed now. Congrats, and stay healthy! Response: We sincerely thank the reviewer for the positive evaluation of our revised manuscript and for recognizing the improvements made based on the previous round of comments. We appreciate the encouraging feedback and are pleased that the manuscript is now considered ready to proceed. We are grateful for the reviewer’s constructive input throughout the review process, which has significantly strengthened the clarity, structure, and overall quality of the work. Change in manuscript: No Change. Reviewer #2: (No Response). Response to Reviewer #2 We sincerely thank the reviewer for their time and for confirming that all previous comments have been adequately addressed. We greatly appreciate the constructive feedback provided in the earlier review rounds, which has helped improve the clarity and quality of the manuscript. Change in manuscript: No Change. Reviewer #3: Dear authors, Thank you so much for all the revision and new version of your article. I have no further comments or questions. Best regards. Response to Reviewer #3 We sincerely thank the reviewer for their thoughtful evaluation and kind feedback. We greatly appreciate the time and effort invested in reviewing our manuscript throughout the revision process. We are pleased that the revised version has addressed all concerns, and we are grateful for the positive assessment. Change in manuscript: No Change. Reviewer #5: (No Response). Response: We sincerely thank the reviewer for their time and for confirming that all previous comments have been adequately addressed. We greatly appreciate the constructive feedback provided in the earlier review rounds, which has helped improve the clarity and quality of the manuscript. Change in manuscript: No Change. Reviewer #6: I thank the authors for their careful review of the manuscript. The updated version presents clear improvements in structure, greater clarity, and alignment between objectives, methods, and results. The manuscript now presents a more balanced and technically sound discussion, and the overall scientific contribution is evident. However, some important methodological limitations remain insufficiently addressed or not explicitly stated, compromising the transparency of the study. Given the proof-of-concept and ex vivo nature of the work, these issues do not invalidate the conclusions, but should be clearly acknowledged to ensure proper interpretation by clinical readers and researchers who wish to use this reference for further study. I strongly recommend, in the interest of a more transparent scientific method, that the authors explicitly include the following points in the limitations section (within the Discussion section): The use of a single specimen (n=1), clarifying that repeated measurements do not increase the number of independent samples (pseudoreplication). The convenience sampling approach and its implications for generalization. The absence of experimental randomization, differentiating it from the randomization used for blind image evaluation. A justification for the absence of normality tests or clarification of any assumptions made (especially relevant for ANOVA/ICC-based analyses). The absence of confidence intervals (e.g., 95%) for sensitivity and specificity, especially considering the limited number of independent events. A clear statement about exclusions or data loss, even if none occurred. These additions are relatively small from a structural point of view, but are essential for methodological transparency and adherence to good reporting practices. Final recommendation: Accept after minor revisions. Response: We thank the reviewer for this constructive recommendation. We have revised the Limitations section to clarify the structure of the dataset and its implications for statistical interpretation. Specifically, we now state that the study was conducted on a single porcine mandible specimen, including multiple teeth analyzed across controlled bone-loss stages. Reviewer point: Single specimen and pseudoreplication Reviewer: 1. The use of a single specimen (n=1), clarifying that repeated measurements do not increase the number of independent samples (pseudoreplication). Response: We further clarify that, although multiple teeth, stages, and repeated measurements were included, these observations do not represent independent biological samples and should be interpreted within a repeated-measurement framework. The potential for pseudoreplication is now explicitly acknowledged. Importantly, we emphasize that this study was designed as a proof-of-concept validation of measurement performance under controlled conditions. Biological factors such as tissue viability, inflammation, soft tissue composition, and in vivo scanning conditions may influence ultrasound signal interaction and image characteristics. For example, imaging in a living model may introduce additional variability compared to an ex vivo specimen. However, these factors are expected to affect measurement conditions rather than the underlying measurement principle. Therefore, while biological variability may influence quantitative performance metrics, the measurement framework and methodology remain applicable across conditions. These clarifications have been incorporated in the Limitations section of the revised manuscript to ensure full methodological transparency. Change in manuscript: Section: Discussion → Limitations Added paragraph: Specifically, we now state that the study was conducted on multiple teeth within a single porcine mandible, with measurements performed across controlled bone-loss stages. We further clarify that, although multiple teeth, stages, and repeated measurements were included, these observations do not represent independent biological samples and should be interpreted within a repeated-measurement framework. The potential for pseudoreplication is now explicitly acknowledged. While this design enables detailed evaluation of measurement performance, it does not capture biological variation between different animals. However, this study was designed as a proof-of-concept validation of measurement performance under controlled conditions, and the measurement framework and methodology remain applicable across conditions. Reviewer point: Convenience sampling Reviewer: 2. The convenience sampling approach and its implications for generalization. Response: We have added a statement clarifying that the specimen was selected by convenience sampling based on availability, intact anatomy, and suitability for controlled defect creation. The implications of this approach for generalizability are now explicitly discussed in the Limitations section. Change in manuscript: Section: Discussion → Limitations Added (within same paragraph): The specimen was selected by convenience sampling based on availability, intact anatomy, and suitability for controlled defect creation. This limits the generalizability of the findings to broader biological variation, different tooth types, different ages, and clinical periodontal conditions. Reviewer point: Absence of experimental randomization Reviewer: 3. The absence of experimental randomization, differentiating it from the randomization used for blind image evaluation. A justification for the absence of normality tests or clarification of any assumptions made (especially relevant for ANOVA/ICC-based analyses). Response: We have clarified that no experimental randomization was performed for specimen selection or defect creation. We further distinguish this from the randomization applied during blinded image evaluation, where images were anonymized and presented in random order to reduce observer bias. Change in manuscript: Section: Discussion → Limitations Added (within same paragraph): No experimental randomization was performed for specimen selection or defect creation. The randomization used in this study applied only to the blinded image-evaluation process, where images were anonymized and presented in random order to reduce observer bias. Reviewer point: Normality assumptions Response: We thank the reviewer for this important comment. We have clarified the assumptions related to normality and the use of ANOVA/ICC analyses in two locations. First, a statement has been added in the Data and Statistical Analysis section to explain that formal normality testing was not systematically performed due to the limited number of independent experimental units, and that analyses were applied within a repeated-measurement reliability framework. Second, this point has been explicitly acknowledged in the Limitations section to ensure transparency regarding statistical assumptions and interpretation. Change in manuscript: Section: Data and Statistical Analysis Added: Due to the limited number of independent experimental units inherent to this proof-of-concept design, formal normality testing was not systematically performed. Instead, baseline error distributions were visually inspected and found to be approximately normal. Accordingly, ANOVA- and ICC-based analyses were applied as measures of internal consistency and reliability within a repeated-measurement framework rather than for population-level inference. Section: Discussion → Limitations Added (within main paragraph): Formal normality testing was not performed for all statistical comparisons due to the limited number of independent experimental units. Baseline error distributions were visually inspected and appeared approximately normally distributed. Therefore, ANOVA- and ICC-based results should be interpreted as measures of internal consistency and reliability within this controlled repeated-measurement framework rather than as population-level inference. Reviewer point: Confidence intervals for sensitivity/specificity Reviewer: 4. The absence of confidence intervals (e.g., 95%) for sensitivity and specificity, especially considering the limited number of independent events. Response: We thank the reviewer for this important comment. Confidence intervals are already reported for reliability metrics (e.g., ICC values, Table 3), where sufficient repeated measurements were available. For diagnostic performance metrics (sensitivity and specificity), these values are presented and interpreted in detail in the Results and Discussion sections (Tables 4–6). However, due to the limited number of independent bone-loss events inherent to this proof-of-concept design, confidence interval estimates for sensitivity, and specificity would be wide and less reliable. Therefore, rather than over-interpreting statistically unstable interval estimates, we have clarified this limitation in the manuscript and emphasized that the reported diagnostic accuracy metrics should be interpreted as preliminary. Change in manuscript: Section: Clinical Translation and Detection Performance Added: Due to the limited number of independent bone-loss events evaluated in this proof-of-concept study, confidence intervals for sensitivity and specificity would be wide and therefore less precise. Accordingly, these estimates should be interpreted with caution and considered preliminary indicators of detection performance rather than definitive measures of diagnostic accuracy. Section: Discussion → Limitations Added (within main paragraph): Confidence intervals for sensitivity and specificity are inherently limited by the small number of independent bone-loss events and may therefore be wide and less reliable. Reviewer point: Exclusions or data loss Reviewer: 5. A clear statement about exclusions or data loss, even if none occurred. Response: We have added an explicit statement confirming that no datasets, images, or measurements were excluded from the analysis and that no data loss occurred. Change in manuscript: Section: Results Already present: No datasets were excluded from the analysis, and all acquired images and measurements were included in the statistical evaluation. Section: Discussion → Limitations Added: No datasets, images, or measurements were excluded from the analysis, and no data loss occurred. Final note These additions are relatively small from a structural point of view but are essential for methodological transparency and adherence to good reporting practices. Final recommendation: Accept after minor revisions. Response: We are grateful for the reviewer’s insightful feedback, which has significantly improved the transparency, clarity, and methodological rigor of the manuscript. Additional note: We added new reference [41] into our reference list. And refer to it at section: “ Anatomical considerations and prior work” Submitted filename: Response to Reviewers_2nd.docx 5 May 2026 Sub-millimeter quantification of alveolar bone loss using automated 40 MHz high-frequency ultrasound: a proof-of-concept ex vivo validation study PONE-D-26-02614R2 Dear Dr. Jokerst, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Andrej M Kielbassa Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--> Reviewer #1: All comments have been addressed Reviewer #6: All comments have been addressed ********** -->2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Yes Reviewer #6: Yes ********** -->3. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: Yes Reviewer #6: Yes ********** -->4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #6: Yes ********** -->5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #6: Yes ********** -->6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: The Co-Authors have adequately responded to all previous and recent comments and recommendation. From my point of view, this revised and re-submitted manuscript could be considerably improved with the help of the Reviewers. In case Reviewer #2 will confirm this view, this piece of work should be worth following, and is considered ready to proceed. Thanks, and good luck with your future work! Reviewer #6: The manuscript has clearly improved compared to its earlier versions, particularly in terms of methodological transparency and the way the study’s limitations are now presented. The authors have made a consistent effort to address previous concerns, especially by explicitly discussing key issues such as the ex vivo nature of the model, the use of a convenience sample, the reliance on a single biological unit (n = 1) with the associated risk of pseudoreplication, the lack of full experimental randomization, the constraints related to the statistical assumptions, and the limited precision of the diagnostic estimates, particularly sensitivity and specificity. Altogether, these revisions strengthen the manuscript and bring it more in line with good scientific reporting practices, allowing for a more balanced interpretation of the findings. From a scientific perspective, the study offers a meaningful, though preliminary, contribution by exploring the potential of an emerging diagnostic approach. The results are interesting and suggest possible applicability, but they should be interpreted with caution. Given the inherent limitations of the study design, the level of certainty of the evidence remains low, especially when considering its translation to real clinical settings. Looking ahead, further research will be important to build on these findings. Studies that include biologically independent and more representative samples, are conducted under in vivo conditions, and use analytical methods that properly account for data dependency will be particularly valuable. In addition, efforts to validate the diagnostic accuracy of this method in real clinical environments, with more robust estimates and appropriate confidence intervals, will be essential to better understand its true clinical value. In its current form, the manuscript is suitable for publication and represents a valid initial step in this line of research. At the same time, its conclusions should be viewed as preliminary, and future studies with stronger methodological designs and external validation will be necessary to consolidate the evidence in this area. ********** -->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No Reviewer #6: No ********** PONE-D-26-02614R2 PLOS One Dear Dr. Jokerst, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Dr. med. dent. Dr. h. c. Andrej M Kielbassa Academic Editor PLOS One